<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Psychiatry</journal-id>
<journal-title>Frontiers in Psychiatry</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Psychiatry</abbrev-journal-title>
<issn pub-type="epub">1664-0640</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fpsyt.2025.1655548</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Psychiatry</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Psychometric validation of the SNAP-IV rating scale in amblyopic children at high AD/HD risk: structural validity and measurement invariance</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Pan</surname>
<given-names>Lu</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ru</surname>
<given-names>Meng</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Huang</surname>
<given-names>Yuxing</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Luo</surname>
<given-names>Wuqiang</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/3101366/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Lili</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/3101411/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Luo</surname>
<given-names>Yan</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/3118532/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lin</surname>
<given-names>Enwei</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/3102518/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kong</surname>
<given-names>Min</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/3119110/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Qi</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2701344/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Luo</surname>
<given-names>Yali</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Hairun</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Huang</surname>
<given-names>Siyan</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zeng</surname>
<given-names>Jin</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/801276/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Han</surname>
<given-names>Fei</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Xiao</surname>
<given-names>Xin</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff7">
<sup>7</sup>
</xref>
<xref ref-type="aff" rid="aff8">
<sup>8</sup>
</xref>
<xref ref-type="aff" rid="aff9">
<sup>9</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2733010/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>The School of Public Health, Guilin Medical University</institution>, <addr-line>Guilin, Guangxi</addr-line>,&#xa0;<country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Visual Science and Optometry Center, The People&#x2019;s Hospital of Guangxi Zhuang Autonomous Region</institution>, <addr-line>Nanning, Guangxi</addr-line>,&#xa0;<country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>School of Public Health, Guangxi Medical University</institution>, <addr-line>Nanning, Guangxi</addr-line>,&#xa0;<country>China</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>School of Public Health and Management, Guangxi University of Chinese Medicine</institution>, <addr-line>Nanning, Guangxi</addr-line>,&#xa0;<country>China</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>Cognitive Sleep Center, The People&#x2019;s Hospital of Guangxi Zhuang Autonomous Region</institution>, <addr-line>Nanning, Guangxi</addr-line>,&#xa0;<country>China</country>
</aff>
<aff id="aff6">
<sup>6</sup>
<institution>Department of Ophthalmology, Guangdong Provincial People&#x2019;s Hospital, Guangdong Academy of Medical Sciences, Southern Medical University</institution>, <addr-line>Guangzhou</addr-line>,&#xa0;<country>China</country>
</aff>
<aff id="aff7">
<sup>7</sup>
<institution>Guangxi Key Laboratory of Eye Health, The People&#x2019;s Hospital of Guangxi Zhuang Autonomous Region</institution>, <addr-line>Nanning, Guangxi</addr-line>,&#xa0;<country>China</country>
</aff>
<aff id="aff8">
<sup>8</sup>
<institution>Guangxi Health Commission Key Laboratory of Ophthalmology and Related Systemic Diseases Artificial Intelligence Screening Technology, The People&#x2019;s Hospital of Guangxi Zhuang Autonomous Region</institution>, <addr-line>Nanning, Guangxi</addr-line>,&#xa0;<country>China</country>
</aff>
<aff id="aff9">
<sup>9</sup>
<institution>Department of Scientific Research, The People&#x2019;s Hospital of Guangxi Zhuang Autonomous Region</institution>, <addr-line>Nanning, Guangxi</addr-line>,&#xa0;<country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Eduardo Fern&#xe1;ndez-Jim&#xe9;nez, European University of Madrid, Spain</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Lorenz S. Neuwirth, State University of New York at Old Westbury, United States</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/3172406/overview">Jane Wotherspoon</ext-link>, Queensland University of Technology, Australia</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Xin Xiao, <email xlink:href="mailto:xiaoxi3891@163.com">xiaoxi3891@163.com</email>
</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>28</day>
<month>10</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>16</volume>
<elocation-id>1655548</elocation-id>
<history>
<date date-type="received">
<day>28</day>
<month>06</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>09</day>
<month>10</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 Pan, Ru, Huang, Luo, Li, Luo, Lin, Kong, Chen, Luo, Liu, Huang, Zeng, Han and Xiao.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Pan, Ru, Huang, Luo, Li, Luo, Lin, Kong, Chen, Luo, Liu, Huang, Zeng, Han and Xiao</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Objective</title>
<p>To validate the psychometric properties of the Swanson, Nolan, and Pelham Rating Scale (SNAP-IV) in amblyopic children at high AD/HD risk and establish its clinical utility for comorbid AD/HD screening.</p>
</sec>
<sec>
<title>Methods</title>
<p>This cross-sectional study utilized baseline data from the China Amblyopia Behavioral Cohort (CABC), which comprises 465 amblyopic children (aged 4&#x2013;17 years). The reliability of the SNAP-IV was comprehensively assessed using Cronbach&#x2019;s alpha and the split-half coefficient. The validity of the SNAP-IV was evaluated using criterion validity with the Conners&#x2019; parent rating scale (CPRS) and construct validity via confirmatory factor analysis (CFA). The measurement invariance of the SNAP-IV across gender and age groups was also investigated.</p>
</sec>
<sec>
<title>Results</title>
<p>The SNAP-IV demonstrated exceptional internal consistency (Cronbach&#x2019;s &#x3b1; = 0.965 [95% CI: 0.958&#x2013;0.972], split-half coefficient = 0.891) and strong criterion validity with the CPRS domains, particularly with respect to the oppositional factor of the SNAP-IV scale, which showed the highest correlation with the conduct problem factor of the Conners&#x2019; Parent Rating Scale (CPRS) (r<sub>s</sub> = 0.837, 95% CI: 0.807&#x2013;0.863, <italic>p</italic>&lt;0.001, large effect). The findings indicated a substantial correlation between inattention and learning problems (r<sub>s</sub> = 0.808, 95% CI: 0.767&#x2013;0.834, <italic>p</italic>&lt;0.001, large effect) and conduct problems (r<sub>s</sub> = 0.719, 95% CI: 0.675&#x2013;0.765, <italic>p</italic>&lt;0.001, large effect). Confirmatory factor analysis confirmed a three-factor structure (inattention, hyperactivity/impulsivity, oppositional) with robust fit indices (<italic>&#x3c7;&#xb2;</italic>/(291) = 1033.4, &#x3c7;&#xb2;/df = 3.551, RMSEA=0.074, CFI=0.92, IFI=0.92), with full measurement invariance confirmed across gender and age groups.</p>
</sec>
<sec>
<title>Conclusions</title>
<p>This study constitutes the first systematic validation of the SNAP-IV in amblyopic children, thereby establishing its robustness for AD/HD screening in visually impaired populations. The scale&#x2019;s standardized application has the potential to enhance the screening of early AD/HD-amblyopia comorbidity and the development of multidisciplinary intervention strategies for integrating visual and behavioral rehabilitation.</p>
</sec>
</abstract>
<kwd-group>
<kwd>SNAP-IV</kwd>
<kwd>validation</kwd>
<kwd>reliability</kwd>
<kwd>amblyopia</kwd>
<kwd>AD/HD</kwd>
<kwd>children</kwd>
</kwd-group>
<contract-num rid="cn001">Guike AB23026047 &#x6842;&#x67ef; AB23026047</contract-num>
<contract-sponsor id="cn001">Guangxi Key Research and Development Program<named-content content-type="fundref-id">10.13039/501100017691</named-content>
</contract-sponsor>
<contract-sponsor id="cn002">Natural Science Foundation of Guangxi Zhuang Autonomous Region<named-content content-type="fundref-id">10.13039/100012547</named-content>
</contract-sponsor>
<contract-sponsor id="cn003">Basic and Applied Basic Research Foundation of Guangdong Province<named-content content-type="fundref-id">10.13039/501100021171</named-content>
</contract-sponsor>
<counts>
<fig-count count="1"/>
<table-count count="7"/>
<equation-count count="0"/>
<ref-count count="58"/>
<page-count count="11"/>
<word-count count="4913"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>ADHD</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>Attention Deficit/Hyper Activity (AD/HD), a neurodevelopmental disorder characterized by inattention, hyperactivity, and impulsivity (<xref ref-type="bibr" rid="B1">1</xref>), has a global prevalence of approximately 4.8% in children (<xref ref-type="bibr" rid="B2">2</xref>), and an estimated prevalence of 9.8% in the United States (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B4">4</xref>). Its persistence into adulthood (<xref ref-type="bibr" rid="B2">2</xref>) and profound impacts on cognitive, behavioral, and psychosocial functioning (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B6">6</xref>) underscore the urgency of early identification and intervention. Emerging evidence reveals a notable comorbidity between amblyopia and AD/HD. The prevalence of amblyopia among children has been documented to be approximately 2.0% in South Korea (<xref ref-type="bibr" rid="B7">7</xref>),1.09% (95% CI: 0.86&#x2013;1.35%) in central&#x2013;southern China (<xref ref-type="bibr" rid="B8">8</xref>), and 0.99% in Taiwan, China (<xref ref-type="bibr" rid="B9">9</xref>). With respect to comorbidity risk, children diagnosed with amblyopia present a 68.7% increased risk of developing AD/HD (OR=1.687, 95% CI: 1.444&#x2013;1.970) in the Republic of Korea (<xref ref-type="bibr" rid="B7">7</xref>), and a 1.81-fold elevated risk in Taiwan, China (HR=1.81, 95% CI: 1.59&#x2013;2.06) (<xref ref-type="bibr" rid="B10">10</xref>). However, AD/HD patients present an 89% higher prevalence of amblyopia (OR=1.89, 95% CI: 1.76&#x2013;2.05) (<xref ref-type="bibr" rid="B11">11</xref>). Given that amblyopia, a visual developmental disorder affecting 1.44% of preschoolers globally (<xref ref-type="bibr" rid="B12">12</xref>), shares pathophysiological mechanisms with AD/HD&#x2014;such as striatal and subcortical neuronal dysfunction affecting executive attention and multisensory integration (<xref ref-type="bibr" rid="B13">13</xref>&#x2013;<xref ref-type="bibr" rid="B16">16</xref>)&#x2014;the co-occurrence of these disorders creates substantial clinical and economic burdens (<xref ref-type="bibr" rid="B17">17</xref>&#x2013;<xref ref-type="bibr" rid="B19">19</xref>).</p>
<p>Despite these intersections, contemporary behavioral evaluations for AD/HD (e.g., the Conners&#x2019; Parent Rating Scale [CPRS] (<xref ref-type="bibr" rid="B20">20</xref>) and the Child Behavior Checklist [CBCL] (<xref ref-type="bibr" rid="B21">21</xref>)) lack specificity for populations affected by amblyopia (<xref ref-type="bibr" rid="B22">22</xref>). Furthermore, three significant limitations pertaining to the current validation of the SNAP-IV exist: (1) Methodological constraints: Previous studies have systematically excluded cohorts with visual impairments, notwithstanding the evidence that visual deficits can significantly modify behavioral phenotypes (e.g., irritability induced by visual fatigue) (<xref ref-type="bibr" rid="B23">23</xref>); (2) Cultural&#x2013;theoretical deficiencies: The adaptation of the SNAP-IV for Chinese populations (<xref ref-type="bibr" rid="B24">24</xref>) remains unvalidated within sensory-impaired groups, prompting concerns regarding its generalizability; and (3) Clinical diagnostic complications: the attention dysfunction associated with amblyopia frequently overlaps with symptoms of visual impairment, resulting in diagnostic misattribution (<xref ref-type="bibr" rid="B17">17</xref>). These limitations pose a threat to timely identification and effective intervention strategies for AD/HD linked to amblyopia.</p>
<p>To address these gaps, this study conducted a systematic psychometric evaluation of the Chinese SNAP-IV in 465 amblyopic children (aged 4&#x2013;17 years) from the China Amblyopia Behavioral Cohort (CABC). Utilizing a multidimensional validation framework, the present study examines internal consistency (Cronbach&#x2019;s &#x3b1;), structural validity via confirmatory factor analysis (CFA), and measurement invariance across gender and age groups.</p>
<p>By establishing the reliability and validity of the SNAP-IV in this understudied population, our study aims to 1) provide evidence-based guidelines for integrating the SNAP-IV into amblyopia-associated AD/HD screening protocols, 2) increase diagnostic precision by clarifying behavioral manifestations related to visual impairment, and 3) reduce healthcare costs through early identification and multidisciplinary interventions. The present research addresses a critical methodological void (<xref ref-type="bibr" rid="B24">24</xref>&#x2013;<xref ref-type="bibr" rid="B28">28</xref>) and offers a translational solution to improve behavioral health outcomes in visually impaired children.</p>
</sec>
<sec id="s2">
<title>Methods</title>
<sec id="s2_1">
<title>Participants</title>
<p>This study recruited 465 amblyopic children aged 4&#x2013;17 years from the China Amblyopia Behavioral Cohort (CABC), a multicenter initiative conducted between April 2024 and May 2026 across Guangxi, Guangdong, and Sichuan Provinces. The sample size was determined via an empirical approach (<xref ref-type="bibr" rid="B29">29</xref>), calculating 5&#x2013;10 times the number of items in the SNAP-IV scale (26 items), yielding a minimum target of 130&#x2013;260 participants.</p>
<p>The inclusion criteria for the study participants were as follows: The subject met the diagnostic criteria for amblyopia of the Chinese Medical Association Ophthalmology Branch (<xref ref-type="bibr" rid="B30">30</xref>), including anisometropic amblyopia (binocular spherical anisometropia &#x2265; 1.5D or cylindrical anisometropia &#x2265; 1.0D), ametropia amblyopia (binocular equivalent spherical anisometropia &lt; 0.75D), and strabismic amblyopia; In addition, the subject had no other eye diseases or related systemic diseases; and no history of eye surgery. The exclusion criteria were as follows: The subject was found to be (1) unable to cooperate with the examination and (2) had other diseases that may affect the development of the central nervous system.</p>
<p>The severity classification criteria for amblyopia were as follows: (1) mild-to-moderate amblyopia, with best-corrected visual acuity (BCVA) lower than the age-specific normal value but &#x2264; 0.6 logMAR; and (2) severe amblyopia, with BCVA &gt; 0.6 logMAR.</p>
<p>This study received ethical approval from the Ethics Committee of the Guangxi Zhuang Autonomous Region People&#x2019;s Hospital (Approval No. KY-KJT-2023-285) and complied with the principles of the Declaration of Helsinki. Written informed consent was obtained from all participants and their guardians.</p>
</sec>
<sec id="s2_2">
<title>Measures</title>
<sec id="s2_2_1">
<title>Demographic data</title>
<p>The demographic data of the participants was collected via questionnaires, encompassing age, gender, parental education level, maternal smoking/alcohol history, family history of amblyopia, family history of myopia, and birth weight of amblyopic children, were collected through questionnaires.</p>
</sec>
<sec id="s2_2_2">
<title>Clinical data</title>
<p>The clinical data of the patients were collected through a comprehensive eye examination, including an assessment of visual acuity, a fundus examination, and an ocular alignment evaluation. At the initial visit, retinoscopy was performed using 1% atropine sulfate-induced ciliary muscle paralysis, and BCVA was converted to the logarithm of the minimum angle of resolution (LogMAR).</p>
</sec>
<sec id="s2_2_3">
<title>Behavioral questionnaires</title>
<p>The questionnaires were conducted through via the Questionnaire Star platform, with parents completing them under the guidance of professionals. The researchers then proceeded to review and process the collected questionnaires, identifying and addressing missing or anomalous values and removing invalid responses.</p>
<p>The SNAP-IV Rating Scale is comprised of 26 items (<xref ref-type="bibr" rid="B31">31</xref>, <xref ref-type="bibr" rid="B32">32</xref>), which constitute three factors: inattention (9 items), hyperactivity/impulsivity (9 items), and oppositional (8 items). The 4-point Likert scale ranges from 0 (none) to 3 (extremely severe) (<xref ref-type="bibr" rid="B24">24</xref>) and is suitable for children aged 6&#x2013;18 years. Although the SNAP-IV/CPRS are normed for children ages 6&#x2013;18 years, prior adaptations have demonstrated adequate validity and reliability in younger children (aged 4&#x2013;5 years) via parental reports (<xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B33">33</xref>).</p>
<p>The conners parent rating scale (CPRS) used in the study is the 48-item version (<xref ref-type="bibr" rid="B34">34</xref>). The CPRS includes five subscales: conduct problem, learning problem, psychosomatic, hyperactivity/impulsivity, and anxiety. The scale utilized is a parallel 4-point rating scale, ranging from 0 to 3. This CPRS version was selected as the criterion measure for validating the SNAP-IV, primarily because of its extensive validation and establishment of normative data in Chinese populations, ensuring cultural appropriateness. The 48-item CPRS is a well-validated and optimal benchmark specifically for establishing criterion validity in this initial study, given its strong conceptual overlap with the SNAP-IV and proven utility in comparable Chinese research.</p>
</sec>
</sec>
<sec id="s2_3">
<title>Statistical analyzes</title>
<p>The data were analyzed via IBM SPSS Statistics 28.0 and AMOS 26.0. Normality was assessed via the Shapiro&#x2013;Wilk test. Descriptive statistics (mean &#xb1; SDs) were used for normally distributed data; medians and interquartile ranges (IQR) were used for skewed data. Categorical variables are reported as frequencies/percentages (n, %). All the statistical tests were two-tailed, and a p-value &lt; 0.05 was considered statistically significant. For comparisons involving multiple groups, Bonferroni-adjusted <italic>post hoc</italic> tests were applied to control for Type I error. To comprehensively convey the magnitude and precision of the findings, 95% confidence intervals (CIs) and specific effect sizes were reported for all key results. The specific effect size metrics used for each type of statistical test were listed as follow and were interpreted according to conventional thresholds.</p>
<sec id="s2_3_1">
<title>Group comparisons</title>
<p>For demographic and clinical characteristics, Cramer&#x2019;s V (phi (&#x3c6;) coefficients or V) were used for chi-square tests, with interpretations as small (0.1), medium (0.3), or large (0.5); for non-normally distributed continuous variables, the effect size rank-biserial correlation (r<sub>r&#x3b2;</sub>) was calculated alongside Mann-Whitney U tests, interpreted similarly to Cohen&#x2019;s guidelines (small: 0.1, medium: 0.3, large: 0.5); and for parametric tests, Cohen&#x2019;s d or &#x3b7;&#xb2; were reported as appropriate.</p>
</sec>
<sec id="s2_3_2">
<title>Item analysis</title>
<p>Spearman&#x2019;s rank correlation coefficients (r<sub>s</sub>) were calculated between items and factors, with the correlation coefficient (r<sub>s</sub>) itself interpreted as the effect size, reported with 95% confidence intervals (CI), where r values indicate effect size (small: 0.1-0.3, medium: 0.3-0.5, large: &gt;0.5). Acceptable item&#x2013;factor correlations were defined as those that were &#x2265; 0.40 (marginally acceptable) (<xref ref-type="bibr" rid="B35">35</xref>).</p>
</sec>
<sec id="s2_3_3">
<title>Reliability assessment</title>
<p>Cronbach&#x2019;s &#x3b1; coefficient and split-half coefficients were used to evaluate the internal consistency of the scale and its factors. Which served as the primary reliability indices. A Cronbach&#x2019;s &#x3b1; coefficient &#x2265; 0.70 was considered acceptable (<xref ref-type="bibr" rid="B36">36</xref>).</p>
</sec>
<sec id="s2_3_4">
<title>Validity evaluation</title>
<p>Criterion-related validity was analyzed via Spearman&#x2019;s correlation analysis to examine the correlation between the SNAP-IV rating scale and each factor of the CPRS dimensions. The correlation coefficient (r<sub>s</sub>) and 95%CI was interpreted as the effect size. Structural validity was assessed via confirmatory factor analysis (CFA). The commonly used fit evaluation indicators are as follows: 1) &#x3c7;&#xb2;/df &lt; 5.0 is an acceptable model; 2) Comparative Fit Index (CFI) and Incremental Fit Index (IFI) &gt; 0.90 are acceptable standards; 3) Root Mean Square Error of Approximation (RMSEA) and Root Mean Square Residual (RMR) &lt; 0.08 are acceptable standards. These fit indices serve as effect size measures for model adequacy. Convergent validity was supported by standardized factor loadings (&#x3bb;) values &gt; 0.50, composite reliability (CR) &gt; 0.70 and average variance extracted (AVE) &gt; 0.50 are ideal values (<xref ref-type="bibr" rid="B36">36</xref>&#x2013;<xref ref-type="bibr" rid="B38">38</xref>). Discriminant validity was assessed using the Fornell-Larcker criterion by comparing the square root of the AVE for each factor with the inter-factor correlations. Additionally, the Maximum Shared Variance (MSV) and the Average Shared Variance (ASV) were calculated. Strong discriminant validity is indicated when the AVE for each construct is greater than its MSV, and simultaneously greater than its ASV.</p>
</sec>
<sec id="s2_3_5">
<title>Measurement invariance</title>
<p>Multigroup CFA was used to evaluate measurement invariance across gender and age. Invariance was tested by sequentially constraining the factor loadings (metric), intercepts (scalar), and residuals (strict) to be equal across groups. Invariance was supported if the change in fit indices between nested models met the following criteria: &#x394;CFI was &lt; 0.01 and &#x394;RMSEA &lt; 0.015 (<xref ref-type="bibr" rid="B39">39</xref>). These difference indices are the critical effect sizes for evaluating measurement invariance.</p>
</sec>
</sec>
</sec>
<sec id="s3" sec-type="results">
<title>Results</title>
<sec id="s3_1">
<title>Demographics and clinical characteristics of amblyopic children</title>
<p>A total of 465 amblyopic children (99.1% valid questionnaires) participated in this study, and their demographics and clinical features are summarized in <xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>. The sample had a mean age of 6.28 &#xb1; 1.87 years, with 67.96% of subjects being aged &#x2264; 6 years and 51.0% being boys. Amblyopia severity was predominantly mild-to-moderate (94.6%), with refractive amblyopia being the most prevalent subtype (63.6%). Stratified analyses (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table S1</bold>
</xref>) revealed no significant gender- or age-related differences in amblyopia severity (all <italic>p</italic> &gt; 0.05, &#x3c6; = 0.005&#x2013;0.041, indicating negligible effects). However, severe amblyopia was associated with poorer BCVA in the worse eye (U=0, <italic>p</italic>&lt;0.001, r<sub>r&#x3b2;</sub> = 0.398, medium effect) and was more prevalent in the anisometropic and strabismic subtypes (&#x3c7;&#xb2; = 17.2, <italic>p</italic>&lt;0.001, Cram&#xe9;r&#x2019;s V=0.192, small effect). Maternal smoking/alcohol history was low (&lt; 5%), and 58.4% of the caregivers had a college-level education or higher. These results indicate that the sample was representative of typical clinical amblyopia populations.</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Demographic and clinical characteristics.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="left">Characteristics</th>
<th valign="middle" align="center">Total (N=465)</th>
</tr>
</thead>
<tbody>
<tr>
<th valign="middle" colspan="2" align="left">Gender (n (%))</th>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;Boy</td>
<td valign="middle" align="center">237 (51.0)</td>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;Girl</td>
<td valign="middle" align="center">228 (49.0)</td>
</tr>
<tr>
<th valign="middle" colspan="2" align="left">Age (years) (n (%))</th>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;&#x2264;6</td>
<td valign="middle" align="center">316 (67.96)</td>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;&gt;6</td>
<td valign="middle" align="center">149 (32.04)</td>
</tr>
<tr>
<th valign="middle" colspan="2" align="left">Family history of amblyopia (n (%))</th>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;Yes</td>
<td valign="middle" align="center">30 (6.5)</td>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;No</td>
<td valign="middle" align="center">435 (93.5)</td>
</tr>
<tr>
<th valign="middle" colspan="2" align="left">Family history of myopia (n (%))</th>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;Yes</td>
<td valign="middle" align="center">87 (18.7)</td>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;No</td>
<td valign="middle" align="center">378 (81.3)</td>
</tr>
<tr>
<th valign="middle" colspan="2" align="left">Parental education (n (%))</th>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;Middle school</td>
<td valign="middle" align="center">103 (22.2)</td>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;High school</td>
<td valign="middle" align="center">90 (19.4)</td>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;College or above</td>
<td valign="middle" align="center">272 (58.4)</td>
</tr>
<tr>
<th valign="middle" colspan="2" align="left">Mother&#x2019;s smoking history (n (%))</th>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;Yes</td>
<td valign="middle" align="center">9 (1.94)</td>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;No</td>
<td valign="middle" align="center">456 (98.06)</td>
</tr>
<tr>
<th valign="middle" colspan="2" align="left">Mother&#x2019;s history of alcohol consumption (n (%))</th>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;Yes</td>
<td valign="middle" align="center">38 (8.17)</td>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;No</td>
<td valign="middle" align="center">427 (91.83)</td>
</tr>
<tr>
<th valign="middle" colspan="2" align="left">Child&#x2019;s birth weight (n (%))</th>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;&#x2264;2500 g</td>
<td valign="middle" align="center">69 (14.8)</td>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;2500~4000 g</td>
<td valign="middle" align="center">376 (80.9)</td>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;&#x2265;4000 g</td>
<td valign="middle" align="center">20 (4.3)</td>
</tr>
<tr>
<th valign="middle" colspan="2" align="left">Types of amblyopia (n (%))</th>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;Ametropic amblyopia</td>
<td valign="middle" align="center">296 (63.6)</td>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;Anisometropic amblyopia</td>
<td valign="middle" align="center">144 (31.0)</td>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;Strabismic amblyopia</td>
<td valign="middle" align="center">25 (5.4)</td>
</tr>
<tr>
<th valign="middle" colspan="2" align="left">Severity of amblyopia (n (%))</th>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;Mild to moderate</td>
<td valign="middle" align="center">440 (94.6)</td>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;Severe</td>
<td valign="middle" align="center">25 (5.4)</td>
</tr>
<tr>
<th valign="middle" colspan="2" align="left">BCVA (Median (P<sub>25</sub>, P<sub>75</sub>))</th>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;Better eye</td>
<td valign="middle" align="center">0.2 (0.1,0.3)</td>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;Worse eye</td>
<td valign="middle" align="center">0.3 (0.2,0.4)</td>
</tr>
<tr>
<th valign="middle" colspan="2" align="left">Subscales (Median (P<sub>25</sub>, P<sub>75</sub>))</th>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;Inattention</td>
<td valign="middle" align="center">0.67 (0.22,1.0)</td>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;Hyperactivity/Impulsivity</td>
<td valign="middle" align="center">0.67 (0.22,1.0)</td>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;Oppositional</td>
<td valign="middle" align="center">0.625 (0.125,1.0)</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s3_2">
<title>Item analysis and factor correlations of the SNAP-IV</title>
<p>As shown in <xref ref-type="table" rid="T2">
<bold>Table&#xa0;2</bold>
</xref>, all the factors were significantly positively correlated after Bonferroni correction (p &lt; 0.001), with correlations ranging from moderate to strong (r<sub>s</sub> = 0.724&#x2013;0.923, large effect). The factor&#x2013;total correlations (r<sub>s</sub> = 0.887&#x2013;0.923, large effect) were consistently greater than the correlations between factors (r<sub>s</sub> = 0.724&#x2013;0.768, large effect), supporting strong internal consistency. The strongest link was observed between inattention and hyperactivity/impulsivity (r<sub>s</sub> = 0.768, 95% CI: 0.715&#x2013;0.795, large effect), followed by moderate associations between inattention and oppositional behavior (r<sub>s</sub> = 0.724, 95% CI: 0.677&#x2013;0.766, large effect) and between hyperactivity/impulsivity and oppositional behavior (r<sub>s</sub> = 0.739, 95% CI: 0.693&#x2013;0.779, large effect). These results confirm the internal homogeneity of each factor and highlight meaningful relationships among core behavioral constructs.</p>
<table-wrap id="T2" position="float">
<label>Table&#xa0;2</label>
<caption>
<p>Spearman correlations of the interfactor and factor-total scores.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="left">Subscales</th>
<th valign="middle" align="left">Inattention</th>
<th valign="middle" align="left">Hyperactivity/Impulsivity</th>
<th valign="middle" align="left">Oppositional</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="left">Inattention</td>
<td valign="middle" align="center">1.00</td>
<td valign="middle" align="center"/>
<td valign="middle" align="center"/>
</tr>
<tr>
<td valign="middle" align="left">Hyperactivity/Impulsivity</td>
<td valign="middle" align="center">0.768 (0.715,0.795) <sup>***</sup>
</td>
<td valign="middle" align="center">1.00</td>
<td valign="middle" align="center"/>
</tr>
<tr>
<td valign="middle" align="left">Oppositional</td>
<td valign="middle" align="center">0.724 (0.677,0.766) <sup>***</sup>
</td>
<td valign="middle" align="center">0.739 (0.693,0.779) <sup>***</sup>
</td>
<td valign="middle" align="center">1.00</td>
</tr>
<tr>
<td valign="middle" align="left">Total</td>
<td valign="middle" align="center">0.903 (0.885,0.919) <sup>***</sup>
</td>
<td valign="middle" align="center">0.923 (0.908,0.936) <sup>***</sup>
</td>
<td valign="middle" align="center">0.887 (0.865,0.905) <sup>***</sup>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Values are Spearman&#x2019;s correlation coefficients (r<sub>s</sub>) with 95% confidence intervals (95% CI) in parentheses.</p>
</fn>
<fn>
<p>*p &lt; 0.05; **p &lt; 0.01; ***p &lt; 0.001.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3_3">
<title>Internal consistency and reliability of the SNAP-IV</title>
<p>As demonstrated in <xref ref-type="table" rid="T3">
<bold>Table&#xa0;3</bold>
</xref>, the reliability results for the SNAP-IV scale are presented. Cronbach&#x2019;s &#x3b1; and split-half coefficients are retained as reliability metrics, which inherently reflect effect size-like properties for internal consistency. The Cronbach&#x2019;s <italic>&#x3b1;</italic> for the total scale is 0.965 (95% CI: 0.958&#x2013;0.972), and the Cronbach&#x2019;s <italic>&#x3b1;</italic> values of each factor are greater than 0.90. The split-half reliability for the total scale is 0.891, and the individual factor coefficients range from 0.844&#x2013;0.904. These metrics exceed the conventional psychometric thresholds (&#x3b1; &#x2265; 0.70), confirming that the SNAP-IV yields stable and reproducible scores in amblyopic children.</p>
<table-wrap id="T3" position="float">
<label>Table&#xa0;3</label>
<caption>
<p>Reliability of the SNAP-IV.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="center">Subscales</th>
<th valign="middle" align="center">Cronbach&#x2019;s &#x3b1;</th>
<th valign="middle" align="center">Split-Half reliability</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="left">Total</td>
<td valign="middle" align="center">0.965</td>
<td valign="middle" align="center">0.891</td>
</tr>
<tr>
<td valign="middle" align="left">Inattention</td>
<td valign="middle" align="center">0.929</td>
<td valign="middle" align="center">0.904</td>
</tr>
<tr>
<td valign="middle" align="left">Hyperactivity/Impulsivity</td>
<td valign="middle" align="center">0.925</td>
<td valign="middle" align="center">0.844</td>
</tr>
<tr>
<td valign="middle" align="left">Oppositional</td>
<td valign="middle" align="center">0.928</td>
<td valign="middle" align="center">0.900</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>p&lt;0.05*, p&lt;0.01**, and p&lt;0.001***.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3_4">
<title>Criterion-related validity with the CPRS</title>
<p>The correlations with the CPRS revealed strong convergent validity (<xref ref-type="table" rid="T4">
<bold>Table&#xa0;4</bold>
</xref>). Overall, the oppositional of the SNAP-IV exhibited the strongest associations, particularly with the conduct problem of the CPRS (r<sub>s</sub> = 0.837, 95% CI: 0.807&#x2013;0.863, <italic>p</italic>&lt;0.001, large effect), indicating a close alignment between behavioral measures of oppositionality across the two instruments. Inattention was strongly correlated with both learning problems (r<sub>s</sub> = 0.808, 95% CI: 0.767&#x2013;0.834, <italic>p</italic>&lt;0.001, large effect) and conduct problems (r<sub>s</sub> = 0.719, 95% CI: 0.675&#x2013;0.765, <italic>p</italic>&lt;0.001, large effect), In contrast, correlations between the SNAP-IV subscales and the psychosomatic and anxiety factors of the CPRS were moderate (r<sub>s</sub> = 0.346&#x2013;0.478, p &lt; 0.001, medium effects), indicating that these dimensions are less directly related to core ADHD symptom domains but still significantly overlap. Collectively, these results provide robust evidence that the SNAP-IV captures behavioral dimensions that are meaningfully associated with established CPRS constructs.</p>
<table-wrap id="T4" position="float">
<label>Table&#xa0;4</label>
<caption>
<p>Spearman correlations of the SNAP-IV and the CPRS.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="left">Subscales</th>
<th valign="middle" align="center">Inattention</th>
<th valign="middle" align="center">Hyperactivity/Impulsivity</th>
<th valign="middle" align="center">Oppositional</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="left">Conduct problem</td>
<td valign="middle" align="center">0.719 (0.675,0.765) <sup>***</sup>
</td>
<td valign="middle" align="center">0.710 (0.660,0.753) <sup>***</sup>
</td>
<td valign="middle" align="center">0.837 (0.807,0.863) <sup>***</sup>
</td>
</tr>
<tr>
<td valign="middle" align="left">Learning problem</td>
<td valign="middle" align="center">0.808 (0.767,0.834) <sup>***</sup>
</td>
<td valign="middle" align="center">0.676 (0.622,0.724) <sup>***</sup>
</td>
<td valign="middle" align="center">0.677 (0.623,0.724) <sup>***</sup>
</td>
</tr>
<tr>
<td valign="middle" align="left">Psychosomatic</td>
<td valign="middle" align="center">0.475 (0.389,0.536) <sup>***</sup>
</td>
<td valign="middle" align="center">0.423 (0.343,0.497) <sup>***</sup>
</td>
<td valign="middle" align="center">0.478 (0.403,0.547) <sup>***</sup>
</td>
</tr>
<tr>
<td valign="middle" align="left">Impulsivity/Hyperactivity</td>
<td valign="middle" align="center">0.627 (0.567,0.681) <sup>***</sup>
</td>
<td valign="middle" align="center">0.673 (0.618,0.721) <sup>***</sup>
</td>
<td valign="middle" align="center">0.696 (0.644,0.741) <sup>***</sup>
</td>
</tr>
<tr>
<td valign="middle" align="left">Anxiety</td>
<td valign="middle" align="center">0.450 (0.371,0.520) <sup>***</sup>
</td>
<td valign="middle" align="center">0.346 (0.261,0.426) <sup>***</sup>
</td>
<td valign="middle" align="center">0.456(0.378,0.527) <sup>***</sup>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Values are Spearman&#x2019;s correlation coefficients (r<sub>s</sub>) with 95% confidence intervals (95% CI) in parentheses.</p>
</fn>
<fn>
<p>*p &lt; 0.05; **p &lt; 0.01; ***p &lt; 0.001.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3_5">
<title>Confirmatory factor analysis</title>
<p>The initial three-factor model demonstrated suboptimal fit (<italic>&#x3c7;&#xb2;</italic>/(296) = 1225.6, <italic>&#x3c7;&#xb2;</italic>/df = 4.141, p &lt; 0.05, RMSEA=0.082, CFI=0.90, IFI=0.90). Model refinement resulted in indices that met to acceptable levels (<italic>&#x3c7;&#xb2;</italic>/(291) = 1033.4, <italic>&#x3c7;&#xb2;</italic>/df = 3.551, <italic>p</italic>&lt;0.05, RMSEA=0.074, CFI=0.92, IFI=0.92; <xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>). The improved fit supports the scale&#x2019;s structural validity in amblyopic populations.</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Standardized path coefficients of the SNAP-IV.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fpsyt-16-1655548-g001.tif">
<alt-text content-type="machine-generated">Diagram showing a structural model with three main constructs: Inattention, Hyperactivity_Impulsivity, and Oppositional. Each construct links to multiple question items (Q1-Q26), represented as rectangles, with corresponding measurement errors (e1-e26) in ovals. Path coefficients are indicated on the arrows connecting constructs to items and between constructs, illustrating the relationships and strengths within the model.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3_6">
<title>Convergent and discriminant validity</title>
<p>The results of the convergent validity study are presented in <xref ref-type="table" rid="T5">
<bold>Table&#xa0;5</bold>
</xref>. Standardized factor loadings exceeded 0.5 (&#x3bb; = 0.619&#x2013;0.847, indicating large effects), with composite reliability (CR=0.924&#x2013;0.928) and average variance explained (AVE=0.50&#x2013;0.57) both meeting psychometric standards. The discriminant validity results in <xref ref-type="table" rid="T6">
<bold>Table&#xa0;6</bold>
</xref> show that the correlation coefficients between the factors range from 0.767 to 0.851, with some exceeding the square root of their respective AVEs. The correlation coefficient between inattention and hyperactivity/impulsivity (<italic>r</italic> =0.851) is greater than the square root value of the AVE (0.769), and the correlation coefficient between hyperactivity/impulsivity and the oppositional factor (<italic>r</italic> =0.811) is greater than the square root value of the AVE (0.762), indicating that some factors are not independent enough and that the discriminant validity needs to be improved. Furthermore, we now include maximum shared variance (MSV=0.724) and average shared variance (ASV=0.657) as supplemental effect size metrics, confirming moderate-to-high shared variance but acceptable discriminant validity per Fornell-Larcker criterion. These indices collectively suggest that while the factors are robust, discriminant validity between them requires improvement.</p>
<table-wrap id="T5" position="float">
<label>Table&#xa0;5</label>
<caption>
<p>Standardized regression coefficients of the SNAP-IV.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" colspan="3" align="center">Item</th>
<th valign="middle" align="center">Estimate</th>
<th valign="middle" align="center">S.E.</th>
<th valign="middle" align="center">p</th>
<th valign="middle" align="center">AVE</th>
<th valign="middle" align="center">CR</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="center">Q1</td>
<td valign="middle" align="center">&lt;&#x2013;&#x2013;&#x2013;</td>
<td valign="middle" align="left">Inattention</td>
<td valign="middle" align="center">0.837</td>
<td valign="middle" align="center"/>
<td valign="middle" align="center"/>
<td valign="middle" align="center">0.591</td>
<td valign="middle" align="center">0.928</td>
</tr>
<tr>
<td valign="middle" align="center">Q2</td>
<td valign="middle" align="center">&lt;&#x2013;&#x2013;&#x2013;</td>
<td valign="middle" align="left">Inattention</td>
<td valign="middle" align="center">0.841</td>
<td valign="middle" align="center">0.044</td>
<td valign="middle" align="center">***</td>
<td valign="middle" align="center"/>
<td valign="middle" align="center"/>
</tr>
<tr>
<td valign="middle" align="center">Q3</td>
<td valign="middle" align="center">&lt;&#x2013;&#x2013;&#x2013;</td>
<td valign="middle" align="left">Inattention</td>
<td valign="middle" align="center">0.772</td>
<td valign="middle" align="center">0.046</td>
<td valign="middle" align="center">***</td>
<td valign="middle" align="center"/>
<td valign="middle" align="center"/>
</tr>
<tr>
<td valign="middle" align="center">Q4</td>
<td valign="middle" align="center">&lt;&#x2013;&#x2013;&#x2013;</td>
<td valign="middle" align="left">Inattention</td>
<td valign="middle" align="center">0.754</td>
<td valign="middle" align="center">0.041</td>
<td valign="middle" align="center">***</td>
<td valign="middle" align="center"/>
<td valign="middle" align="center"/>
</tr>
<tr>
<td valign="middle" align="center">Q5</td>
<td valign="middle" align="center">&lt;&#x2013;&#x2013;&#x2013;</td>
<td valign="middle" align="left">Inattention</td>
<td valign="middle" align="center">0.740</td>
<td valign="middle" align="center">0.042</td>
<td valign="middle" align="center">***</td>
<td valign="middle" align="center"/>
<td valign="middle" align="center"/>
</tr>
<tr>
<td valign="middle" align="center">Q6</td>
<td valign="middle" align="center">&lt;&#x2013;&#x2013;&#x2013;</td>
<td valign="middle" align="left">Inattention</td>
<td valign="middle" align="center">0.771</td>
<td valign="middle" align="center">0.044</td>
<td valign="middle" align="center">***</td>
<td valign="middle" align="center"/>
<td valign="middle" align="center"/>
</tr>
<tr>
<td valign="middle" align="center">Q7</td>
<td valign="middle" align="center">&lt;&#x2013;&#x2013;&#x2013;</td>
<td valign="middle" align="left">Inattention</td>
<td valign="middle" align="center">0.731</td>
<td valign="middle" align="center">0.048</td>
<td valign="middle" align="center">***</td>
<td valign="middle" align="center"/>
<td valign="middle" align="center"/>
</tr>
<tr>
<td valign="middle" align="center">Q8</td>
<td valign="middle" align="center">&lt;&#x2013;&#x2013;&#x2013;</td>
<td valign="middle" align="left">Inattention</td>
<td valign="middle" align="center">0.790</td>
<td valign="middle" align="center">0.049</td>
<td valign="middle" align="center">***</td>
<td valign="middle" align="center"/>
<td valign="middle" align="center"/>
</tr>
<tr>
<td valign="middle" align="center">Q9</td>
<td valign="middle" align="center">&lt;&#x2013;&#x2013;&#x2013;</td>
<td valign="middle" align="left">Inattention</td>
<td valign="middle" align="center">0.667</td>
<td valign="middle" align="center">0.045</td>
<td valign="middle" align="center">***</td>
<td valign="middle" align="center"/>
<td valign="middle" align="center"/>
</tr>
<tr>
<td valign="middle" align="center">Q10</td>
<td valign="middle" align="center">&lt;&#x2013;&#x2013;&#x2013;</td>
<td valign="middle" align="left">Hyperactivity/Impulsivity</td>
<td valign="middle" align="center">0.794</td>
<td valign="middle" align="center"/>
<td valign="middle" align="center"/>
<td valign="middle" align="center">0.581</td>
<td valign="middle" align="center">0.925</td>
</tr>
<tr>
<td valign="middle" align="center">Q11</td>
<td valign="middle" align="center">&lt;&#x2013;&#x2013;&#x2013;</td>
<td valign="middle" align="left">Hyperactivity/Impulsivity</td>
<td valign="middle" align="center">0.742</td>
<td valign="middle" align="center">0.043</td>
<td valign="middle" align="center">***</td>
<td valign="middle" align="center"/>
<td valign="middle" align="center"/>
</tr>
<tr>
<td valign="middle" align="center">Q12</td>
<td valign="middle" align="center">&lt;&#x2013;&#x2013;&#x2013;</td>
<td valign="middle" align="left">Hyperactivity/Impulsivity</td>
<td valign="middle" align="center">0.809</td>
<td valign="middle" align="center">0.052</td>
<td valign="middle" align="center">***</td>
<td valign="middle" align="center"/>
<td valign="middle" align="center"/>
</tr>
<tr>
<td valign="middle" align="center">Q13</td>
<td valign="middle" align="center">&lt;&#x2013;&#x2013;&#x2013;</td>
<td valign="middle" align="left">Hyperactivity/Impulsivity</td>
<td valign="middle" align="center">0.847</td>
<td valign="middle" align="center">0.047</td>
<td valign="middle" align="center">***</td>
<td valign="middle" align="center"/>
<td valign="middle" align="center"/>
</tr>
<tr>
<td valign="middle" align="center">Q14</td>
<td valign="middle" align="center">&lt;&#x2013;&#x2013;&#x2013;</td>
<td valign="middle" align="left">Hyperactivity/Impulsivity</td>
<td valign="middle" align="center">0.800</td>
<td valign="middle" align="center">0.057</td>
<td valign="middle" align="center">***</td>
<td valign="middle" align="center"/>
<td valign="middle" align="center"/>
</tr>
<tr>
<td valign="middle" align="center">Q15</td>
<td valign="middle" align="center">&lt;&#x2013;&#x2013;&#x2013;</td>
<td valign="middle" align="left">Hyperactivity/Impulsivity</td>
<td valign="middle" align="center">0.681</td>
<td valign="middle" align="center">0.058</td>
<td valign="middle" align="center">***</td>
<td valign="middle" align="center"/>
<td valign="middle" align="center"/>
</tr>
<tr>
<td valign="middle" align="center">Q16</td>
<td valign="middle" align="center">&lt;&#x2013;&#x2013;&#x2013;</td>
<td valign="middle" align="left">Hyperactivity/Impulsivity</td>
<td valign="middle" align="center">0.748</td>
<td valign="middle" align="center">0.050</td>
<td valign="middle" align="center">***</td>
<td valign="middle" align="center"/>
<td valign="middle" align="center"/>
</tr>
<tr>
<td valign="middle" align="center">Q17</td>
<td valign="middle" align="center">&lt;&#x2013;&#x2013;&#x2013;</td>
<td valign="middle" align="left">Hyperactivity/Impulsivity</td>
<td valign="middle" align="center">0.698</td>
<td valign="middle" align="center">0.040</td>
<td valign="middle" align="center">***</td>
<td valign="middle" align="center"/>
<td valign="middle" align="center"/>
</tr>
<tr>
<td valign="middle" align="center">Q18</td>
<td valign="middle" align="center">&lt;&#x2013;&#x2013;&#x2013;</td>
<td valign="middle" align="left">Hyperactivity/Impulsivity</td>
<td valign="middle" align="center">0.725</td>
<td valign="middle" align="center">0.047</td>
<td valign="middle" align="center">***</td>
<td valign="middle" align="center"/>
<td valign="middle" align="center"/>
</tr>
<tr>
<td valign="middle" align="center">Q19</td>
<td valign="middle" align="center">&lt;&#x2013;&#x2013;&#x2013;</td>
<td valign="middle" align="left">Oppositional</td>
<td valign="middle" align="center">0.772</td>
<td valign="middle" align="center"/>
<td valign="middle" align="center"/>
<td valign="middle" align="center">0.605</td>
<td valign="middle" align="center">0.924</td>
</tr>
<tr>
<td valign="middle" align="center">Q20</td>
<td valign="middle" align="center">&lt;&#x2013;&#x2013;&#x2013;</td>
<td valign="middle" align="left">Oppositional</td>
<td valign="middle" align="center">0.804</td>
<td valign="middle" align="center">0.055</td>
<td valign="middle" align="center">***</td>
<td valign="middle" align="center"/>
<td valign="middle" align="center"/>
</tr>
<tr>
<td valign="middle" align="center">Q21</td>
<td valign="middle" align="center">&lt;&#x2013;&#x2013;&#x2013;</td>
<td valign="middle" align="left">Oppositional</td>
<td valign="middle" align="center">0.820</td>
<td valign="middle" align="center">0.052</td>
<td valign="middle" align="center">***</td>
<td valign="middle" align="center"/>
<td valign="middle" align="center"/>
</tr>
<tr>
<td valign="middle" align="center">Q22</td>
<td valign="middle" align="center">&lt;&#x2013;&#x2013;&#x2013;</td>
<td valign="middle" align="left">Oppositional</td>
<td valign="middle" align="center">0.793</td>
<td valign="middle" align="center">0.052</td>
<td valign="middle" align="center">***</td>
<td valign="middle" align="center"/>
<td valign="middle" align="center"/>
</tr>
<tr>
<td valign="middle" align="center">Q23</td>
<td valign="middle" align="center">&lt;&#x2013;&#x2013;&#x2013;</td>
<td valign="middle" align="left">Oppositional</td>
<td valign="middle" align="center">0.793</td>
<td valign="middle" align="center">0.051</td>
<td valign="middle" align="center">***</td>
<td valign="middle" align="center"/>
<td valign="middle" align="center"/>
</tr>
<tr>
<td valign="middle" align="center">Q24</td>
<td valign="middle" align="center">&lt;&#x2013;&#x2013;&#x2013;</td>
<td valign="middle" align="left">Oppositional</td>
<td valign="middle" align="center">0.822</td>
<td valign="middle" align="center">0.054</td>
<td valign="middle" align="center">***</td>
<td valign="middle" align="center"/>
<td valign="middle" align="center"/>
</tr>
<tr>
<td valign="middle" align="center">Q25</td>
<td valign="middle" align="center">&lt;&#x2013;&#x2013;&#x2013;</td>
<td valign="middle" align="left">Oppositional</td>
<td valign="middle" align="center">0.782</td>
<td valign="middle" align="center">0.050</td>
<td valign="middle" align="center">***</td>
<td valign="middle" align="center"/>
<td valign="middle" align="center"/>
</tr>
<tr>
<td valign="middle" align="center">Q26</td>
<td valign="middle" align="center">&lt;&#x2013;&#x2013;&#x2013;</td>
<td valign="middle" align="left">Oppositional</td>
<td valign="middle" align="center">0.619</td>
<td valign="middle" align="center">0.040</td>
<td valign="middle" align="center">***</td>
<td valign="middle" align="center"/>
<td valign="middle" align="center"/>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>p&lt;0.05*, p&lt;0.01**, and p&lt;0.001***.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="T6" position="float">
<label>Table&#xa0;6</label>
<caption>
<p>Discriminant validity of the SNAP-IV.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="left">Variables</th>
<th valign="middle" align="center">Inattention</th>
<th valign="middle" align="center">Hyperactivity/Impulsivity</th>
<th valign="middle" align="center">Oppositional</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="left">Inattention</td>
<td valign="middle" align="center">0.591</td>
<td valign="middle" align="center"/>
<td valign="middle" align="center"/>
</tr>
<tr>
<td valign="middle" align="left">Hyperactivity/Impulsivity</td>
<td valign="middle" align="center">0.851<sup>***</sup>
</td>
<td valign="middle" align="center">0.581</td>
<td valign="middle" align="center"/>
</tr>
<tr>
<td valign="middle" align="left">Oppositional</td>
<td valign="middle" align="center">0.767<sup>***</sup>
</td>
<td valign="middle" align="center">0.811<sup>***</sup>
</td>
<td valign="middle" align="center">0.605</td>
</tr>
<tr>
<td valign="middle" align="left">Square root of AVE</td>
<td valign="middle" align="center">0.769</td>
<td valign="middle" align="center">0.762</td>
<td valign="middle" align="center">0.778</td>
</tr>
<tr>
<td valign="middle" align="left">MSV (Maximum Shared Variance)</td>
<td valign="middle" align="center">0.724</td>
<td valign="middle" align="center">0.724</td>
<td valign="middle" align="center">0.724</td>
</tr>
<tr>
<td valign="middle" align="left">ASV (Average Shared Variance)</td>
<td valign="middle" align="center">0.657</td>
<td valign="middle" align="center">0.657</td>
<td valign="middle" align="center">0.657</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Square root of AVE is compared with inter-factor correlations for discriminant validity. MSV and ASV are included as supplementary indicators of discriminant validity; p&lt;0.05*, p&lt;0.01**, and p&lt;0.001***.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3_7">
<title>Measurement invariance</title>
<p>Measurement invariance for gender and age groups was evaluated via the three-factor model, with the results summarized in <xref ref-type="table" rid="T7">
<bold>Table&#xa0;7</bold>
</xref>. &#x394;CFI and &#x394;RMSEA are reported as effect sizes for model differences (e.g., for gender scalar invariance: &#x394;CFI=-0.002, small effect; &#x394;RMSEA=-0.001, negligible effect). Both groups showed an acceptable fit in the configural model (RMSEA=0.063, CFI=0.885, RMR=0.028 for gender; RMSEA=0.063, CFI=0.886, RMR=0.331 for age). The fit of the metric, scalar, and strict factor models was similar to that of the configural model (&#x394;RMSEA &lt; 0.015, &#x394;CFI &lt; 0.01), thereby supporting measurement invariance across gender and age groups.</p>
<table-wrap id="T7" position="float">
<label>Table&#xa0;7</label>
<caption>
<p>Multigroup CFA fit indices for the SNAP-IV across gender and age.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="left">Model (gender)</th>
<th valign="middle" align="center">&#x3c7;2</th>
<th valign="middle" align="center">df</th>
<th valign="middle" align="center">&#x394;&#x3c7;2</th>
<th valign="middle" align="center">&#x394;df</th>
<th valign="middle" align="center">
<italic>p</italic>
</th>
<th valign="middle" align="center">CFI</th>
<th valign="middle" align="center">RMSEA</th>
<th valign="middle" align="center">RMR</th>
<th valign="middle" align="center">&#x394;CFI</th>
<th valign="middle" align="center">&#x394;RMSEA</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="left">Model1 (configural invariance)</td>
<td valign="middle" align="center">1669.454</td>
<td valign="middle" align="center">592</td>
<td valign="middle" align="center"/>
<td valign="middle" align="center"/>
<td valign="middle" align="center"/>
<td valign="middle" align="center">0.885</td>
<td valign="middle" align="center">0.063</td>
<td valign="middle" align="center">0.028</td>
<td valign="middle" align="center"/>
<td valign="middle" align="center"/>
</tr>
<tr>
<td valign="middle" align="left">Model2 (metric invariance)</td>
<td valign="middle" align="center">1690.035</td>
<td valign="middle" align="center">615</td>
<td valign="middle" align="center">20.581</td>
<td valign="middle" align="center">23</td>
<td valign="middle" align="center">0.607</td>
<td valign="middle" align="center">0.885</td>
<td valign="middle" align="center">0.061</td>
<td valign="middle" align="center">0.031</td>
<td valign="middle" align="center">0</td>
<td valign="middle" align="center">-0.002</td>
</tr>
<tr>
<td valign="middle" align="left">Model3 (scalar invariance)</td>
<td valign="middle" align="center">1713.67</td>
<td valign="middle" align="center">621</td>
<td valign="middle" align="center">44.216</td>
<td valign="middle" align="center">29</td>
<td valign="middle" align="center">0.035</td>
<td valign="middle" align="center">0.883</td>
<td valign="middle" align="center">0.062</td>
<td valign="middle" align="center">0.043</td>
<td valign="middle" align="center">-0.002</td>
<td valign="middle" align="center">-0.001</td>
</tr>
<tr>
<td valign="middle" align="left">Model4 (strict invariance)</td>
<td valign="middle" align="center">1770.387</td>
<td valign="middle" align="center">647</td>
<td valign="middle" align="center">100.933</td>
<td valign="middle" align="center">55</td>
<td valign="middle" align="center">0.000</td>
<td valign="middle" align="center">0.88</td>
<td valign="middle" align="center">0.061</td>
<td valign="middle" align="center">0.044</td>
<td valign="middle" align="center">-0.005</td>
<td valign="middle" align="center">-0.002</td>
</tr>
<tr>
<th valign="middle" colspan="11" align="left">Model (age)</th>
</tr>
<tr>
<td valign="middle" align="left">Model1 (configural invariance)</td>
<td valign="middle" align="center">1664.644</td>
<td valign="middle" align="center">592</td>
<td valign="middle" align="center"/>
<td valign="middle" align="center"/>
<td valign="middle" align="center"/>
<td valign="middle" align="center">0.886</td>
<td valign="middle" align="center">0.063</td>
<td valign="middle" align="center">0.031</td>
<td valign="middle" align="center"/>
<td valign="middle" align="center"/>
</tr>
<tr>
<td valign="middle" align="left">Model2 (metric invariance)</td>
<td valign="middle" align="center">1691.426</td>
<td valign="middle" align="center">615</td>
<td valign="middle" align="center">26.782</td>
<td valign="middle" align="center">23</td>
<td valign="middle" align="center">0.265</td>
<td valign="middle" align="center">0.886</td>
<td valign="middle" align="center">0.061</td>
<td valign="middle" align="center">0.037</td>
<td valign="middle" align="center">0</td>
<td valign="middle" align="center">-0.002</td>
</tr>
<tr>
<td valign="middle" align="left">Model3 (scalar invariance)</td>
<td valign="middle" align="center">1697.805</td>
<td valign="middle" align="center">621</td>
<td valign="middle" align="center">33.161</td>
<td valign="middle" align="center">29</td>
<td valign="middle" align="center">0.271</td>
<td valign="middle" align="center">0.886</td>
<td valign="middle" align="center">0.061</td>
<td valign="middle" align="center">0.055</td>
<td valign="middle" align="center">0</td>
<td valign="middle" align="center">-0.002</td>
</tr>
<tr>
<td valign="middle" align="left">Model4 (strict invariance)</td>
<td valign="middle" align="center">1780.282</td>
<td valign="middle" align="center">647</td>
<td valign="middle" align="center">115.638</td>
<td valign="middle" align="center">55</td>
<td valign="middle" align="center">0.000</td>
<td valign="middle" align="center">0.88</td>
<td valign="middle" align="center">0.062</td>
<td valign="middle" align="center">0.056</td>
<td valign="middle" align="center">-0.006</td>
<td valign="middle" align="center">-0.001</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>p&lt;0.05*, p&lt;0.01**, and p&lt;0.001***.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<title>Discussions</title>
<sec id="s4_1">
<title>Key findings and psychometric robustness</title>
<p>This study represents the first systematic psychometric evaluation of the SNAP-IV rating scale in amblyopic children at high AD/HD risk, demonstrating exceptional reliability and validity. The scale exhibited outstanding internal consistency, surpassing previous cross-cultural adaptations in Brazil (<italic>&#x3b1;</italic> &gt; 0.91) and China (<italic>&#x3b1;</italic> =0.88&#x2013;0.90) (<xref ref-type="bibr" rid="B24">24</xref>, <xref ref-type="bibr" rid="B28">28</xref>). These findings serve to reinforce the stability of the SNAP-IV in capturing homogenous behavioral constructs across diverse populations. The findings of the factorial analysis provided further support for the construct validity of the scale, with strong correlations between factors, indicating that all items reliably discriminate their respective dimensions (<xref ref-type="bibr" rid="B40">40</xref>, <xref ref-type="bibr" rid="B41">41</xref>).</p>
<p>Importantly, the observed effect sizes across the main psychometric indices ranged from medium to large, highlighting that the associations observed are not only statistically significant but also of practical and clinical importance. Convergent validity with the CPRS was robust, particularly with respect to the oppositional factor of the SNAP-IV scale, which showed a large effect size correlation with the conduct problem factor of the CPRS (r<sub>s</sub> = 0.837, <italic>p &lt;</italic>0.001), which is consistent with evidence that children with unilateral visual impairment frequently present with heightened behavioral difficulties, including externalizing symptoms (<xref ref-type="bibr" rid="B23">23</xref>). Notably, large correlations between inattention and behavior problems (with learning problems and conduct problems, all <italic>p &lt;</italic>0.001) underscore that attentional deficits exert a substantial behavioral impact in visually impaired children. Such magnitudes suggest that these relationships reflect meaningful behavioral mechanisms rather than trivial statistical findings. The large effect sizes observed support the hypothesis that attentional resource allocation deficits secondary to visual impairment, manifesting as cascading behavioral sequelae (<xref ref-type="bibr" rid="B42">42</xref>), thereby supporting theories of symptom overlap in neurodevelopmental disorders (<xref ref-type="bibr" rid="B43">43</xref>, <xref ref-type="bibr" rid="B44">44</xref>). Together, these results demonstrate both statistical robustness and real-world relevance, underscoring the need for integrated interventions that addressing both visual symptoms and behavioral comorbidities in children with amblyopia.</p>
</sec>
<sec id="s4_2">
<title>Factor structure and measurement invariance</title>
<p>The three-factor model of the SNAP-IV (inattention, hyperactivity/impulsivity, oppositional) is illustrated in <xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>. This model demonstrated strong cross-cultural adaptability with acceptable fit indices (p &lt; 0.05) (<xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B41">41</xref>, <xref ref-type="bibr" rid="B45">45</xref>). However, initial model misfit (RMSEA=0.082) highlighted insufficient factor independence, a finding that is probably attributable to the clinical co-occurrence of AD/HD symptoms (<xref ref-type="bibr" rid="B44">44</xref>) and nonspecific behavioral responses to visual dysfunction (<xref ref-type="bibr" rid="B46">46</xref>). As depicted in <xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>, the standardized path coefficients ranged from 0.62 to 0.85, corresponding to large effect sizes, which affirm both the statistical robustness and the practical interpretability of the model. These magnitudes indicate that items have substantial loading strength on their latent constructs, advancing SNAP-IV understanding by confirming its factor structure in amblyopic children-a previously untested domain-and supporting its use for nuanced ADHD subtyping in visual impairment contexts. A high proportion of individuals &#x2264;6 years of age (67.96%) may attenuate age norms, but invariance tests confirmed their applicability. Similarly, the measurement invariance across gender groups further corroborated the scale&#x2019;s applicability across demographic subgroups.</p>
<p>However, configural and metric invariance were maintained (&#x394;&#x3c7;&#xb2; = 26.782, &#x394;df = 23, <italic>p</italic> =0.265), and the small-to-medium effect size differences observed at the intercept level (&#x394;RMSEA = 0.001, &#x394;CFI = 0.006), which may reflect variations in behavioral expression due to age and environmental factors. This aligns with developmental trends showing declining hyperactivity with increasing age (<xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B24">24</xref>). These effects are modest yet informative, emphasizing the need for age-adjusted thresholds in clinical practice. Furthermore, small effect size differences were detected across gender in scalar and strict invariance models (both <italic>p</italic>&lt;0.05, &#x394;RMSEA &lt; 0.005, &#x394;CFI &lt; 0.002), with behavioral patterns consistent with clinical features of AD/HD (<xref ref-type="bibr" rid="B47">47</xref>). The minimal magnitude of these differences suggests they represent true behavioral variation rather than measurement bias. The small magnitude of these differences indicates they reflect genuine behavioral variation rather than measurement bias. Cross-cultural evidence suggests that these gender differences cannot be attributed to reporter bias or differences in assessment tools (<xref ref-type="bibr" rid="B48">48</xref>). These insights underscore the necessity of gender-sensitive assessment protocols in pediatric populations.</p>
</sec>
<sec id="s4_3">
<title>Clinical and theoretical implications</title>
<p>The SNAP-IV scale has demonstrated strong reliability and validity across various cultural adaptations (<xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B49">49</xref>, <xref ref-type="bibr" rid="B50">50</xref>), underscoring its clinical value in assessing behavioral issues in amblyopic children. The validated reliability and validity of the SNAP-IV in this understudied population provide a critical tool for the early identification of AD/HD comorbidities in amblyopic children. Given that a high percentage of amblyopic children develop AD/HD-related behaviors (<xref ref-type="bibr" rid="B51">51</xref>) and that visual treatment windows is typically limited to age 7 (<xref ref-type="bibr" rid="B52">52</xref>), this scale offers timely clinical utility. Our findings align with transactional developmental theory (<xref ref-type="bibr" rid="B42">42</xref>, <xref ref-type="bibr" rid="B53">53</xref>), suggesting that visual impairment disrupts attentional processes, which in turn exacerbate behavioral outcomes. The overlap between attentional difficulties and visual impairment may further complicate diagnostic processes, underscoring the need for precise, population-specific assessment protocols. This mechanistic framework justifies multidisciplinary interventions targeting both sensory and behavioral domains in children with amblyopia. From the perspective of multidisciplinary management of amblyopia, the results of this study provide a practical tool for the comprehensive assessment and intervention of children with amblyopia, ultimately leading to better long-term outcomes for these children.</p>
</sec>
<sec id="s4_4">
<title>Limitations and future directions</title>
<p>While groundbreaking, this study has several limitations. First, parent-reported data introduced potential reporter bias, as both the SNAP-IV and the CPRS were completed by caregivers (<xref ref-type="bibr" rid="B54">54</xref>). Second, the absence of a clinical AD/HD diagnosis group precluded sensitivity/specificity analysis. Third, the cross-sectional design provided limited insights into the temporal stability of the scale. Fourth, both the authors and the participants in this study belong to the same ethnic and cultural group, potentially influencing the results through in-group familiarity with subtle behavioral norms (<xref ref-type="bibr" rid="B42">42</xref>). Caution is warranted when generalizing findings to other populations. Last but still important, while the SNAP-IV/CPRS lack age/gender norms (unlike Conners-4), they were chosen for validated Chinese adaptations in pediatric cohorts and brevity for clinical feasibility. Future research should incorporate teacher and self-reports to triangulate data, longitudinal tracking to assess developmental trajectories (<xref ref-type="bibr" rid="B55">55</xref>, <xref ref-type="bibr" rid="B56">56</xref>), and validation against gold-standard diagnostic interviews (e.g., Conners-4) (<xref ref-type="bibr" rid="B57">57</xref>). Additionally, optimizing items for age-specific expression (e.g., preschool vs. school-age) and incorporating neurocognitive measures (e.g., eye-tracking, fMRI) could enhance discriminative validity (<xref ref-type="bibr" rid="B58">58</xref>).</p>
</sec>
</sec>
<sec id="s5" sec-type="conclusions">
<title>Conclusions</title>
<p>This study establishes the SNAP-IV as a reliable and valid instrument for assessing AD/HD-related behaviors in amblyopic children, filling a critical gap in developmental psychology research. While measurement invariance was largely preserved, age- and gender-related variations necessitate refined calibration for clinical use. Future advancements should prioritize longitudinal validation and multidisciplinary integration to address the complex interplay between visual impairment and behavioral comorbidities, ultimately improving long-term developmental outcomes for these vulnerable children.</p>
</sec>
</body>
<back>
<sec id="s7" sec-type="data-availability">
<title>Data availability statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec id="s8" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>The studies involving humans were approved by the ethics committee of People&#x2019;s Hospital of Guangxi Zhuang Autonomous Region (Approval No: KY-KJT-2023-285). The studies were conducted in accordance with the local legislation and institutional requirements. Written informed consent for participation in this study was provided by the participants&#x2019; legal guardians/next of kin.</p>
</sec>
<sec id="s9" sec-type="author-contributions">
<title>Author contributions</title>
<p>LP: Data curation, Investigation, Writing &#x2013; original draft. MR: Data curation, Formal analysis, Writing &#x2013; original draft. YH: Data curation, Investigation, Writing &#x2013; original draft. WL: Investigation, Validation, Writing &#x2013; original draft. LL: Data curation, Investigation, Writing &#x2013; original draft. YL: Data curation, Investigation, Writing &#x2013; original draft.&#xa0;EL: Data curation, Investigation, Writing &#x2013; original draft. MK: Investigation, Validation, Writing &#x2013; original draft. QC: Data curation, Investigation, Validation, Writing &#x2013; original draft. YaL:&#xa0;Data curation, Investigation, Writing &#x2013; original draft. HL: Formal analysis, Writing &#x2013; original draft. SH: Formal analysis, Writing &#x2013; original draft. JZ: Conceptualization, Funding acquisition, Methodology, Writing &#x2013; review &amp; editing. FH: Methodology, Writing &#x2013; review &amp; editing. XX: Conceptualization, Funding acquisition, Methodology, Writing &#x2013; review &amp; editing.</p>
</sec>
<sec id="s10" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare financial support was received for the research and/or publication of this article. This study was supported by the Guangxi Key Research and Development Program (No. Guike AB23026047), Guangxi Natural Science Foundation (2024GXNSFAA010262), Guangdong Basic and Applied Basic Research Foundation (2021A1515011822), Guangxi Medical and Health Appropriate Technology Research and Development Project (2023003), and Guangxi Clinical Ophthalmic Research Center (No. Guike AD19245193). All funding parties did not have any role in the study design, conduct of this research, data analysis, or decisions in preparation or publishing of the manuscript.</p>
</sec>
<ack>
<title>Acknowledgments</title>
<p>The authors wish to express their sincere gratitude to Professor Jian Song for his professional native English editing, which has significantly improved the readability and quality of the manuscript.</p>
</ack>
<sec id="s11" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s12" sec-type="ai-statement">
<title>Generative AI statement</title>
<p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If&#xa0;you identify any issues, please contact us.</p>
</sec>
<sec id="s13" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors&#xa0;and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s14" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fpsyt.2025.1655548/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fpsyt.2025.1655548/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="Table1.docx" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thapar</surname> <given-names>A</given-names>
</name>
<name>
<surname>Cooper</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Attention deficit hyperactivity disorder</article-title>. <source>Lancet (London England)</source>. (<year>2016</year>) <volume>387</volume>:<page-range>1240&#x2013;50</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s0140-6736(15)00238-x</pub-id>, PMID: <pub-id pub-id-type="pmid">26386541</pub-id></citation></ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Popit</surname> <given-names>S</given-names>
</name>
<name>
<surname>Serod</surname> <given-names>K</given-names>
</name>
<name>
<surname>Locatelli</surname> <given-names>I</given-names>
</name>
<name>
<surname>Stuhec</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Prevalence of attention-deficit hyperactivity disorder (ADHD): systematic review and meta-analysis</article-title>. <source>Eur Psychiatry</source>. (<year>2024</year>) <volume>67</volume>:<fpage>e68</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1192/j.eurpsy.2024.1786</pub-id>, PMID: <pub-id pub-id-type="pmid">39381949</pub-id></citation></ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bozinovic</surname> <given-names>K</given-names>
</name>
<name>
<surname>McLamb</surname> <given-names>F</given-names>
</name>
<name>
<surname>O&#x2019;Connell</surname> <given-names>K</given-names>
</name>
<name>
<surname>Olander</surname> <given-names>N</given-names>
</name>
<name>
<surname>Feng</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Haagensen</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>U.S. National, regional, and state-specific socioeconomic factors correlate with child and adolescent ADHD diagnoses pre-Covid-19 pandemic</article-title>. <source>Sci Rep</source>. (<year>2021</year>) <volume>11</volume>:<fpage>22008</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-021-01233-2</pub-id>, PMID: <pub-id pub-id-type="pmid">34759326</pub-id></citation></ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peterson</surname> <given-names>BS</given-names>
</name>
<name>
<surname>Trampush</surname> <given-names>J</given-names>
</name>
<name>
<surname>Maglione</surname> <given-names>M</given-names>
</name>
<name>
<surname>Bolshakova</surname> <given-names>M</given-names>
</name>
<name>
<surname>Rozelle</surname> <given-names>M</given-names>
</name>
<name>
<surname>Miles</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Treatments for ADHD in children and adolescents: A systematic review</article-title>. <source>Pediatrics</source>. (<year>2024</year>) <volume>153</volume>:<elocation-id>e2024065787</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1542/peds.2024-065787</pub-id>, PMID: <pub-id pub-id-type="pmid">38523592</pub-id></citation></ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Posner</surname> <given-names>J</given-names>
</name>
<name>
<surname>Polanczyk</surname> <given-names>GV</given-names>
</name>
<name>
<surname>Sonuga-Barke</surname> <given-names>E</given-names>
</name>
</person-group>. <article-title>Attention-deficit hyperactivity disorder</article-title>. <source>Lancet (London England)</source>. (<year>2020</year>) <volume>395</volume>:<page-range>450&#x2013;62</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s0140-6736(19)33004-1</pub-id>, PMID: <pub-id pub-id-type="pmid">31982036</pub-id></citation></ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mohr-Jensen</surname> <given-names>C</given-names>
</name>
<name>
<surname>Steinhausen</surname> <given-names>HC</given-names>
</name>
</person-group>. <article-title>A meta-analysis and systematic review of the risks associated with childhood attention-deficit hyperactivity disorder on long-term outcome of arrests, convictions, and incarcerations</article-title>. <source>Clin Psychol Rev</source>. (<year>2016</year>) <volume>48</volume>:<fpage>32</fpage>&#x2013;<lpage>42</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cpr.2016.05.002</pub-id>, PMID: <pub-id pub-id-type="pmid">27390061</pub-id></citation></ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname> <given-names>M</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>S</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>JE</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>JH</given-names>
</name>
<name>
<surname>Ha</surname> <given-names>EK</given-names>
</name>
<name>
<surname>Han</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>A nationwide cohort study on the risk of ADHD in children with amblyopia mediated by fine motor skill impairment in East Asia</article-title>. <source>Sci Rep</source>. (<year>2022</year>) <volume>12</volume>:<fpage>6932</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-022-10845-1</pub-id>, PMID: <pub-id pub-id-type="pmid">35484195</pub-id></citation></ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>YP</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>MW</given-names>
</name>
<name>
<surname>Forster</surname> <given-names>SH</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>SY</given-names>
</name>
<name>
<surname>Qi</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>HM</given-names>
</name>
<etal/>
</person-group>. <article-title>Prevalence of amblyopia among preschool children in central south China</article-title>. <source>Int J Ophthalmol</source>. (<year>2019</year>) <volume>12</volume>:<page-range>820&#x2013;5</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.18240/ijo.2019.05.19</pub-id>, PMID: <pub-id pub-id-type="pmid">31131243</pub-id></citation></ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname> <given-names>B</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zeng</surname> <given-names>L</given-names>
</name>
<name>
<surname>Hao</surname> <given-names>G</given-names>
</name>
<name>
<surname>Shui</surname> <given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>The global prevalence of amblyopia in children: A systematic review and meta-analysis</article-title>. <source>Front Pediatr</source>. (<year>2022</year>) <volume>10</volume>:<elocation-id>819998</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fped.2022.819998</pub-id>, PMID: <pub-id pub-id-type="pmid">35601430</pub-id></citation></ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Su</surname> <given-names>CC</given-names>
</name>
<name>
<surname>Tsai</surname> <given-names>CY</given-names>
</name>
<name>
<surname>Tsai</surname> <given-names>TH</given-names>
</name>
<name>
<surname>Tsai</surname> <given-names>IJ</given-names>
</name>
</person-group>. <article-title>Incidence and risk of attention-deficit hyperactivity disorder in children with amblyopia: A nationwide cohort study</article-title>. <source>Clin Exp Ophthalmol</source>. (<year>2019</year>) <volume>47</volume>:<page-range>259&#x2013;64</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/ceo.13465</pub-id>, PMID: <pub-id pub-id-type="pmid">30663207</pub-id></citation></ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ho</surname> <given-names>JD</given-names>
</name>
<name>
<surname>Sheu</surname> <given-names>JJ</given-names>
</name>
<name>
<surname>Kao</surname> <given-names>YW</given-names>
</name>
<name>
<surname>Shia</surname> <given-names>BC</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>HC</given-names>
</name>
</person-group>. <article-title>Associations between attention-deficit/hyperactivity disorder and ocular abnormalities in children: A population-based study</article-title>. <source>Ophthalmic Epidemiol</source>. (<year>2020</year>) <volume>27</volume>:<page-range>194&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/09286586.2019.1704795</pub-id>, PMID: <pub-id pub-id-type="pmid">31878821</pub-id></citation></ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fu</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Hong</surname> <given-names>H</given-names>
</name>
<name>
<surname>Su</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Lou</surname> <given-names>B</given-names>
</name>
<name>
<surname>Pan</surname> <given-names>CW</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Global prevalence of amblyopia and disease burden projections through 2040: A systematic review and meta-analysis</article-title>. <source>Br J Ophthalmol</source>. (<year>2020</year>) <volume>104</volume>:<page-range>1164&#x2013;70</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1136/bjophthalmol-2019-314759</pub-id>, PMID: <pub-id pub-id-type="pmid">31704700</pub-id></citation></ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hubel</surname> <given-names>DH</given-names>
</name>
<name>
<surname>Wiesel</surname> <given-names>TN</given-names>
</name>
<name>
<surname>LeVay</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Plasticity of ocular dominance columns in monkey striate cortex</article-title>. <source>Philos Trans R Soc London Ser B Biol Sci</source>. (<year>1977</year>) <volume>278</volume>:<fpage>377</fpage>&#x2013;<lpage>409</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1098/rstb.1977.0050</pub-id>, PMID: <pub-id pub-id-type="pmid">19791</pub-id></citation></ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mortazavi</surname> <given-names>M</given-names>
</name>
<name>
<surname>Aigner</surname> <given-names>KM</given-names>
</name>
<name>
<surname>Antono</surname> <given-names>JE</given-names>
</name>
<name>
<surname>Gambacorta</surname> <given-names>C</given-names>
</name>
<name>
<surname>Nahum</surname> <given-names>M</given-names>
</name>
<name>
<surname>Levi</surname> <given-names>DM</given-names>
</name>
<etal/>
</person-group>. <article-title>Neural correlates of visual spatial selective attention are altered at early and late processing stages in human amblyopia</article-title>. <source>Eur J Neurosci</source>. (<year>2021</year>) <volume>53</volume>:<page-range>1086&#x2013;106</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/ejn.15024</pub-id>, PMID: <pub-id pub-id-type="pmid">33107117</pub-id></citation></ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Niechwiej-Szwedo</surname> <given-names>E</given-names>
</name>
<name>
<surname>Colpa</surname> <given-names>L</given-names>
</name>
<name>
<surname>Wong</surname> <given-names>AMF</given-names>
</name>
</person-group>. <article-title>Visuomotor behaviour in amblyopia: deficits and compensatory adaptations</article-title>. <source>Neural plasticity</source>. (<year>2019</year>) <volume>2019</volume>:<elocation-id>6817839</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2019/6817839</pub-id>, PMID: <pub-id pub-id-type="pmid">31281344</pub-id></citation></ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wong</surname> <given-names>AM</given-names>
</name>
</person-group>. <article-title>New concepts concerning the neural mechanisms of amblyopia and their clinical implications</article-title>. <source>Can J Ophthalmol J canadien d&#x2019;ophtalmologie</source>. (<year>2012</year>) <volume>47</volume>:<fpage>399</fpage>&#x2013;<lpage>409</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jcjo.2012.05.002</pub-id>, PMID: <pub-id pub-id-type="pmid">23036539</pub-id></citation></ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Randhawa</surname> <given-names>S</given-names>
</name>
<name>
<surname>Griffiths</surname> <given-names>N</given-names>
</name>
<name>
<surname>O&#x2019;Brien</surname> <given-names>P</given-names>
</name>
<name>
<surname>Panter</surname> <given-names>C</given-names>
</name>
<name>
<surname>Boparai</surname> <given-names>K</given-names>
</name>
<name>
<surname>Harrad</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>Qualitative exploration of the visual function impairments and health-related quality of life impacts of amblyopia in adult and pediatric populations</article-title>. <source>Ophthalmol Ther</source>. (<year>2023</year>) <volume>12</volume>:<page-range>2505&#x2013;28</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s40123-023-00751-8</pub-id>, PMID: <pub-id pub-id-type="pmid">37356087</pub-id></citation></ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gupte-Singh</surname> <given-names>K</given-names>
</name>
<name>
<surname>Singh</surname> <given-names>RR</given-names>
</name>
<name>
<surname>Lawson</surname> <given-names>KA</given-names>
</name>
</person-group>. <article-title>Economic burden of attention-deficit/hyperactivity disorder among pediatric patients in the United States</article-title>. <source>Value Health</source>. (<year>2017</year>) <volume>20</volume>:<page-range>602&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jval.2017.01.007</pub-id>, PMID: <pub-id pub-id-type="pmid">28408002</pub-id></citation></ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Malvankar-Mehta</surname> <given-names>MS</given-names>
</name>
<name>
<surname>Wilson</surname> <given-names>R</given-names>
</name>
<name>
<surname>Leci</surname> <given-names>E</given-names>
</name>
<name>
<surname>Hatch</surname> <given-names>K</given-names>
</name>
<name>
<surname>Sharan</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Cost and quality of life of overlooked eye care needs of children</article-title>. <source>Risk Manage healthcare Policy</source>. (<year>2018</year>) <volume>11</volume>:<fpage>25</fpage>&#x2013;<lpage>33</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.2147/rmhp.s141659</pub-id>, PMID: <pub-id pub-id-type="pmid">29503589</pub-id></citation></ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Conners</surname> <given-names>CK</given-names>
</name>
<name>
<surname>Sitarenios</surname> <given-names>G</given-names>
</name>
<name>
<surname>Parker</surname> <given-names>JD</given-names>
</name>
<name>
<surname>Epstein</surname> <given-names>JN</given-names>
</name>
</person-group>. <article-title>The revised conners&#x2019; Parent rating scale (Cprs-R): factor structure, reliability, and criterion validity</article-title>. <source>J Abnormal Child Psychol</source>. (<year>1998</year>) <volume>26</volume>:<page-range>257&#x2013;68</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1023/a:1022602400621</pub-id>, PMID: <pub-id pub-id-type="pmid">9700518</pub-id></citation></ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neo</surname> <given-names>WS</given-names>
</name>
<name>
<surname>Suzuki</surname> <given-names>T</given-names>
</name>
<name>
<surname>Kelleher</surname> <given-names>BL</given-names>
</name>
</person-group>. <article-title>Structural validity of the child behavior checklist (Cbcl) for preschoolers with neurogenetic syndromes</article-title>. <source>Res Dev Disabil</source>. (<year>2021</year>) <volume>109</volume>:<elocation-id>103834</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ridd.2020.103834</pub-id>, PMID: <pub-id pub-id-type="pmid">33360964</pub-id></citation></ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sibley</surname> <given-names>MH</given-names>
</name>
</person-group>. <article-title>Empirically-informed guidelines for first-time adult Adhd diagnosis</article-title>. <source>J Clin Exp Neuropsychol</source>. (<year>2021</year>) <volume>43</volume>:<page-range>340&#x2013;51</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/13803395.2021.1923665</pub-id>, PMID: <pub-id pub-id-type="pmid">33949916</pub-id></citation></ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Celano</surname> <given-names>M</given-names>
</name>
<name>
<surname>Cotsonis</surname> <given-names>GA</given-names>
</name>
<name>
<surname>Hartmann</surname> <given-names>EE</given-names>
</name>
<name>
<surname>Drews-Botsch</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>Behaviors of children with unilateral vision impairment in the infant Aphakia treatment study</article-title>. <source>J AAPOS</source>. (<year>2016</year>) <volume>20</volume>:<page-range>320&#x2013;5</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jaapos.2016.04.008</pub-id>, PMID: <pub-id pub-id-type="pmid">27424046</pub-id></citation></ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gau</surname> <given-names>SS</given-names>
</name>
<name>
<surname>Shang</surname> <given-names>CY</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>SK</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>CH</given-names>
</name>
<name>
<surname>Swanson</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>YC</given-names>
</name>
<etal/>
</person-group>. <article-title>Psychometric properties of the Chinese version of the Swanson, Nolan, and Pelham, version iv scale - parent form</article-title>. <source>Int J Methods Psychiatr Res</source>. (<year>2008</year>) <volume>17</volume>:<fpage>35</fpage>&#x2013;<lpage>44</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/mpr.237</pub-id>, PMID: <pub-id pub-id-type="pmid">18286459</pub-id></citation></ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Faganello</surname> <given-names>IB</given-names>
</name>
<name>
<surname>Zomerfeld</surname> <given-names>MD</given-names>
</name>
<name>
<surname>de Oliveira</surname> <given-names>RE</given-names>
</name>
<name>
<surname>da Paix&#xe3;o</surname> <given-names>TC</given-names>
</name>
<name>
<surname>Gemelli</surname> <given-names>H</given-names>
</name>
<name>
<surname>de Carvalho</surname> <given-names>MD</given-names>
</name>
<etal/>
</person-group>. <article-title>Application of snap-iv scale on children with academic underachievement</article-title>. <source>SBN Conf</source>. (<year>2023</year>) <volume>A064</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1055/s-0043-1774483</pub-id>
</citation></ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tamm</surname> <given-names>L</given-names>
</name>
<name>
<surname>Denton</surname> <given-names>CA</given-names>
</name>
<name>
<surname>Epstein</surname> <given-names>JN</given-names>
</name>
<name>
<surname>Schatschneider</surname> <given-names>C</given-names>
</name>
<name>
<surname>Taylor</surname> <given-names>H</given-names>
</name>
<name>
<surname>Arnold</surname> <given-names>LE</given-names>
</name>
<etal/>
</person-group>. <article-title>Comparing treatments for children with ADHD and word reading difficulties: A randomized clinical trial</article-title>. <source>J consulting Clin Psychol</source>. (<year>2017</year>) <volume>85</volume>:<page-range>434&#x2013;46</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1037/ccp0000170</pub-id>, PMID: <pub-id pub-id-type="pmid">28333510</pub-id></citation></ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lundervold</surname> <given-names>AJ</given-names>
</name>
<name>
<surname>S&#xf8;rensen</surname> <given-names>L</given-names>
</name>
<name>
<surname>Posserud</surname> <given-names>MB</given-names>
</name>
<name>
<surname>Hysing</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Low persistence of inattention symptoms from childhood to adolescence: A population-based study</article-title>. <source>J attention Disord</source>. (<year>2023</year>) <volume>27</volume>:<page-range>1532&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1177/10870547231187147</pub-id>, PMID: <pub-id pub-id-type="pmid">37496456</pub-id></citation></ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Costa</surname> <given-names>DS</given-names>
</name>
<name>
<surname>de Paula</surname> <given-names>JJ</given-names>
</name>
<name>
<surname>Malloy-Diniz</surname> <given-names>LF</given-names>
</name>
<name>
<surname>Romano-Silva</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Miranda</surname> <given-names>DM</given-names>
</name>
</person-group>. <article-title>Parent snap-iv rating of attention-deficit/hyperactivity disorder: accuracy in a clinical sample of ADHD, validity, and reliability in a Brazilian sample</article-title>. <source>Jornal pediatria</source>. (<year>2019</year>) <volume>95</volume>:<page-range>736&#x2013;43</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jped.2018.06.014</pub-id>, PMID: <pub-id pub-id-type="pmid">30236592</pub-id></citation></ref>
<ref id="B29">
<label>29</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>de Vet</surname> <given-names>HCW</given-names>
</name>
<name>
<surname>Terwee</surname> <given-names>CB</given-names>
</name>
<name>
<surname>Mokkink</surname> <given-names>LB</given-names>
</name>
<name>
<surname>Knol</surname> <given-names>DL</given-names>
</name>
</person-group>. <source>Measurement in Medicine: A Practical Guide</source>. <publisher-loc>Cambridge</publisher-loc>: <publisher-name>Cambridge University Press</publisher-name> (<year>2011</year>).</citation></ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<collab>Strabismus; CAfPOa</collab>
<collab>Association POaSGoCO</collab>
</person-group>. <article-title>Expert consensus on prevention and treatment of amblyopia in children</article-title>. <source>[Zhonghua yan ke za zhi] Chin J Ophthalmol</source>. (<year>2021</year>) <volume>57</volume>:<page-range>336&#x2013;40</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3760/cma.j.cn112142-20210109-00014</pub-id>, PMID: <pub-id pub-id-type="pmid">33915635</pub-id></citation></ref>
<ref id="B31">
<label>31</label>
<citation citation-type="web">
<article-title>Child ADHD snap iv</article-title>. Available online at: <uri xlink:href="https://greenspacehealth.com/en-ca/child-adhd-snap-iv-26/">https://greenspacehealth.com/en-ca/child-adhd-snap-iv-26/</uri> (Accessed <access-date>April 18, 2025</access-date>).</citation></ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bussing</surname> <given-names>R</given-names>
</name>
<name>
<surname>Fernandez</surname> <given-names>M</given-names>
</name>
<name>
<surname>Harwood</surname> <given-names>M</given-names>
</name>
<name>
<surname>Wei</surname> <given-names>H</given-names>
</name>
<name>
<surname>Garvan</surname> <given-names>CW</given-names>
</name>
<name>
<surname>Eyberg</surname> <given-names>SM</given-names>
</name>
<etal/>
</person-group>. <article-title>Parent and teacher snap-iv ratings of attention deficit hyperactivity disorder symptoms: psychometric properties and normative ratings from a school district sample</article-title>. <source>Assessment</source>. (<year>2008</year>) <volume>15</volume>:<page-range>317&#x2013;28</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1177/1073191107313888</pub-id>, PMID: <pub-id pub-id-type="pmid">18310593</pub-id></citation></ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>L&#xfa;cio</surname> <given-names>PS</given-names>
</name>
<name>
<surname>Eid</surname> <given-names>M</given-names>
</name>
<name>
<surname>Cogo-Moreira</surname> <given-names>H</given-names>
</name>
<name>
<surname>Puglisi</surname> <given-names>ML</given-names>
</name>
<name>
<surname>Polanczyk</surname> <given-names>GV</given-names>
</name>
</person-group>. <article-title>Investigating the measurement invariance and method-trait effects of parent and teacher snap-iv ratings of preschool children</article-title>. <source>Child Psychiatry Hum Dev</source>. (<year>2022</year>) <volume>53</volume>:<fpage>489</fpage>&#x2013;<lpage>501</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s10578-021-01145-2</pub-id>, PMID: <pub-id pub-id-type="pmid">33638743</pub-id></citation></ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goyette</surname> <given-names>CH</given-names>
</name>
<name>
<surname>Conners</surname> <given-names>CK</given-names>
</name>
<name>
<surname>Ulrich</surname> <given-names>RF</given-names>
</name>
</person-group>. <article-title>Normative data on revised conners parent and teacher rating scales</article-title>. <source>J Abnormal Child Psychol</source>. (<year>1978</year>) <volume>6</volume>:<page-range>221&#x2013;36</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/bf00919127</pub-id>, PMID: <pub-id pub-id-type="pmid">670589</pub-id></citation></ref>
<ref id="B35">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cella</surname> <given-names>D</given-names>
</name>
<name>
<surname>Lenderking</surname> <given-names>WR</given-names>
</name>
<name>
<surname>Chongpinitchai</surname> <given-names>P</given-names>
</name>
<name>
<surname>Bushmakin</surname> <given-names>AG</given-names>
</name>
<name>
<surname>Dina</surname> <given-names>O</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Functional assessment of chronic illness therapy-fatigue is a reliable and valid measure in patients with active ankylosing spondylitis</article-title>. <source>J patient-reported outcomes</source>. (<year>2022</year>) <volume>6</volume>:<fpage>100</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s41687-022-00508-0</pub-id>, PMID: <pub-id pub-id-type="pmid">36138330</pub-id></citation></ref>
<ref id="B36">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Str&#xf6;mbeck</surname> <given-names>J</given-names>
</name>
<name>
<surname>Heyne</surname> <given-names>D</given-names>
</name>
<name>
<surname>Ferrer-Wreder</surname> <given-names>L</given-names>
</name>
<name>
<surname>Alanko</surname> <given-names>K</given-names>
</name>
</person-group>. <article-title>Reliability and validity of the Swedish version of the inventory of school attendance problems (Isap)</article-title>. <source>Eur Child Adolesc Psychiatry</source>. (<year>2024</year>) <volume>34</volume>:<page-range>2069&#x2013;82</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00787-024-02618-0</pub-id>, PMID: <pub-id pub-id-type="pmid">39607485</pub-id></citation></ref>
<ref id="B37">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname> <given-names>R</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>H</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Psychometric properties of the caregiver strain questionnaire among Chinese parents of children with ADHD or ASD</article-title>. <source>Gen Psychiatry</source>. (<year>2021</year>) <volume>34</volume>:<elocation-id>e100246</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1136/gpsych-2020-100246</pub-id>, PMID: <pub-id pub-id-type="pmid">33782658</pub-id></citation></ref>
<ref id="B38">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fornell</surname> <given-names>C</given-names>
</name>
<name>
<surname>Larcker</surname> <given-names>DF</given-names>
</name>
</person-group>. <article-title>Structural equation models with unobservable variables and measurement error: algebra and statistics</article-title>. <source>J Marketing Res</source>. (<year>1981</year>) <volume>18</volume>:<page-range>382&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1177/002224378101800313</pub-id>
</citation></ref>
<ref id="B39">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Riglin</surname> <given-names>L</given-names>
</name>
<name>
<surname>Dennison</surname> <given-names>C</given-names>
</name>
<name>
<surname>Martin</surname> <given-names>J</given-names>
</name>
<name>
<surname>Tseliou</surname> <given-names>F</given-names>
</name>
<name>
<surname>Armitage</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Shakeshaft</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Emotional Problems across Development: Examining Measurement Invariance across Childhood, Adolescence and Early Adulthood</article-title>. <source>Eur Child Adolesc Psychiatry</source>. (<year>2024</year>) <volume>33</volume>:<page-range>4237&#x2013;45</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00787-024-02461-3</pub-id>, PMID: <pub-id pub-id-type="pmid">38755320</pub-id></citation></ref>
<ref id="B40">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zieff</surname> <given-names>MR</given-names>
</name>
<name>
<surname>Hoogenhout</surname> <given-names>M</given-names>
</name>
<name>
<surname>Eastman</surname> <given-names>E</given-names>
</name>
<name>
<surname>Christ</surname> <given-names>BU</given-names>
</name>
<name>
<surname>Galvin</surname> <given-names>A</given-names>
</name>
<name>
<surname>de Menil</surname> <given-names>V</given-names>
</name>
<etal/>
</person-group>. <article-title>Validity of the snap-iv for ADHD assessment in South African children with neurodevelopmental disorders</article-title>. <source>J Autism Dev Disord</source>. (<year>2023</year>) <volume>53</volume>:<page-range>2851&#x2013;62</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s10803-022-05530-1</pub-id>, PMID: <pub-id pub-id-type="pmid">35451673</pub-id></citation></ref>
<ref id="B41">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abhayaratna</surname> <given-names>HC</given-names>
</name>
<name>
<surname>Ariyasinghe</surname> <given-names>DI</given-names>
</name>
<name>
<surname>Ginige</surname> <given-names>P</given-names>
</name>
<name>
<surname>Chandradasa</surname> <given-names>M</given-names>
</name>
<name>
<surname>Hansika</surname> <given-names>KS</given-names>
</name>
<name>
<surname>Fernando</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Psychometric properties of the sinhala version of the swanson, nolan, and pelham rating scale (Snap-iv) parent form in healthy children and children with ADHD</article-title>. <source>Asian J Psychiatry</source>. (<year>2023</year>) <volume>83</volume>:<elocation-id>103542</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ajp.2023.103542</pub-id>, PMID: <pub-id pub-id-type="pmid">36963301</pub-id></citation></ref>
<ref id="B42">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Verghese</surname> <given-names>P</given-names>
</name>
<name>
<surname>McKee</surname> <given-names>SP</given-names>
</name>
<name>
<surname>Levi</surname> <given-names>DM</given-names>
</name>
</person-group>. <article-title>Attention deficits in amblyopia</article-title>. <source>Curr Opin Psychol</source>. (<year>2019</year>) <volume>29</volume>:<fpage>199</fpage>&#x2013;<lpage>204</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.copsyc.2019.03.011</pub-id>, PMID: <pub-id pub-id-type="pmid">31030000</pub-id></citation></ref>
<ref id="B43">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frick</surname> <given-names>PJ</given-names>
</name>
<name>
<surname>Nigg</surname> <given-names>JT</given-names>
</name>
</person-group>. <article-title>Current issues in the diagnosis of attention deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder</article-title>. <source>Annu Rev Clin Psychol</source>. (<year>2012</year>) <volume>8</volume>:<fpage>77</fpage>&#x2013;<lpage>107</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1146/annurev-clinpsy-032511-143150</pub-id>, PMID: <pub-id pub-id-type="pmid">22035245</pub-id></citation></ref>
<ref id="B44">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Willcutt</surname> <given-names>EG</given-names>
</name>
<name>
<surname>Nigg</surname> <given-names>JT</given-names>
</name>
<name>
<surname>Pennington</surname> <given-names>BF</given-names>
</name>
<name>
<surname>Solanto</surname> <given-names>MV</given-names>
</name>
<name>
<surname>Rohde</surname> <given-names>LA</given-names>
</name>
<name>
<surname>Tannock</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>Validity of dsm-iv attention deficit/hyperactivity disorder symptom dimensions and subtypes</article-title>. <source>J Abnormal Psychol</source>. (<year>2012</year>) <volume>121</volume>:<fpage>991</fpage>&#x2013;<lpage>1010</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1037/a0027347</pub-id>, PMID: <pub-id pub-id-type="pmid">22612200</pub-id></citation></ref>
<ref id="B45">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nazeer</surname> <given-names>N</given-names>
</name>
<name>
<surname>Rohanachandra</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Prathapan</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Prevalence of ADHD in primary school children, in Colombo district, Sri Lanka</article-title>. <source>J attention Disord</source>. (<year>2022</year>) <volume>26</volume>:<page-range>1130&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1177/10870547211058704</pub-id>, PMID: <pub-id pub-id-type="pmid">34784810</pub-id></citation></ref>
<ref id="B46">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Black</surname> <given-names>AA</given-names>
</name>
<name>
<surname>Wood</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Hoang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Thomas</surname> <given-names>E</given-names>
</name>
<name>
<surname>Webber</surname> <given-names>AL</given-names>
</name>
</person-group>. <article-title>Impact of amblyopia on visual attention and visual search in children</article-title>. <source>Invest Ophthalmol Visual Sci</source>. (<year>2021</year>) <volume>62</volume>:<elocation-id>15</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1167/iovs.62.4.15</pub-id>, PMID: <pub-id pub-id-type="pmid">33848323</pub-id></citation></ref>
<ref id="B47">
<label>47</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lambek</surname> <given-names>R</given-names>
</name>
<name>
<surname>Trillingsgaard</surname> <given-names>A</given-names>
</name>
<name>
<surname>Kadesj&#xf6;</surname> <given-names>B</given-names>
</name>
<name>
<surname>Damm</surname> <given-names>D</given-names>
</name>
<name>
<surname>Thomsen</surname> <given-names>PH</given-names>
</name>
</person-group>. <article-title>Gender differences on the five to fifteen questionnaire in a non-referred sample with inattention and hyperactivity-impulsivity and a clinic-referred sample with hyperkinetic disorder</article-title>. <source>Scandinavian J Psychol</source>. (<year>2010</year>) <volume>51</volume>:<page-range>540&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1467-9450.2010.00825.x</pub-id>, PMID: <pub-id pub-id-type="pmid">20602741</pub-id></citation></ref>
<ref id="B48">
<label>48</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Crijnen</surname> <given-names>AA</given-names>
</name>
<name>
<surname>Achenbach</surname> <given-names>TM</given-names>
</name>
<name>
<surname>Verhulst</surname> <given-names>FC</given-names>
</name>
</person-group>. <article-title>Problems reported by parents of children in multiple cultures: the child behavior checklist syndrome constructs</article-title>. <source>Am J Psychiatry</source>. (<year>1999</year>) <volume>156</volume>:<page-range>569&#x2013;74</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1176/ajp.156.4.569</pub-id>, PMID: <pub-id pub-id-type="pmid">10200736</pub-id></citation></ref>
<ref id="B49">
<label>49</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Inoue</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Ito</surname> <given-names>K</given-names>
</name>
<name>
<surname>Kita</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Inagaki</surname> <given-names>M</given-names>
</name>
<name>
<surname>Kaga</surname> <given-names>M</given-names>
</name>
<name>
<surname>Swanson</surname> <given-names>JM</given-names>
</name>
</person-group>. <article-title>Psychometric properties of Japanese version of the Swanson, Nolan, and Pelham, version-iv scale-teacher form: A study of school children in community samples</article-title>. <source>Brain Dev</source>. (<year>2014</year>) <volume>36</volume>:<page-range>700&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.braindev.2013.09.003</pub-id>, PMID: <pub-id pub-id-type="pmid">24075708</pub-id></citation></ref>
<ref id="B50">
<label>50</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jusoh</surname> <given-names>M</given-names>
</name>
<name>
<surname>Dzulkarnain</surname> <given-names>AAA</given-names>
</name>
<name>
<surname>Rahmat</surname> <given-names>S</given-names>
</name>
<name>
<surname>Musa</surname> <given-names>R</given-names>
</name>
<name>
<surname>Che Azemin</surname> <given-names>MZ</given-names>
</name>
</person-group>. <article-title>Cross-cultural translation and validation of the Malay version of the Swanson, Nolan, and Pelham parent rating scale of attention deficit hyperactivity disorders symptoms among Malaysian probands: A preliminary study</article-title>. <source>Asia-Pacific Psychiatry</source>. (<year>2021</year>) <volume>13</volume>:<elocation-id>e12414</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/appy.12414</pub-id>, PMID: <pub-id pub-id-type="pmid">32815284</pub-id></citation></ref>
<ref id="B51">
<label>51</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Webber</surname> <given-names>AL</given-names>
</name>
</person-group>. <article-title>The functional impact of amblyopia</article-title>. <source>Clin Exp optometry</source>. (<year>2018</year>) <volume>101</volume>:<page-range>443&#x2013;50</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/cxo.12663</pub-id>, PMID: <pub-id pub-id-type="pmid">29484704</pub-id></citation></ref>
<ref id="B52">
<label>52</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sengpiel</surname> <given-names>F</given-names>
</name>
</person-group>. <article-title>Plasticity of the visual cortex and treatment of amblyopia</article-title>. <source>Curr biology: CB</source>. (<year>2014</year>) <volume>24</volume>:<page-range>R936&#x2013;r40</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cub.2014.05.063</pub-id>, PMID: <pub-id pub-id-type="pmid">25247373</pub-id></citation></ref>
<ref id="B53">
<label>53</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sameroff</surname> <given-names>AJ</given-names>
</name>
<name>
<surname>Mackenzie</surname> <given-names>MJ</given-names>
</name>
</person-group>. <article-title>Research strategies for capturing transactional models of development: the limits of the possible</article-title>. <source>Dev Psychopathol</source>. (<year>2003</year>) <volume>15</volume>:<page-range>613&#x2013;40</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1017/s0954579403000312</pub-id>, PMID: <pub-id pub-id-type="pmid">14582934</pub-id></citation></ref>
<ref id="B54">
<label>54</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weden</surname> <given-names>MM</given-names>
</name>
<name>
<surname>Brownell</surname> <given-names>PB</given-names>
</name>
<name>
<surname>Rendall</surname> <given-names>MS</given-names>
</name>
<name>
<surname>Lau</surname> <given-names>C</given-names>
</name>
<name>
<surname>Fernandes</surname> <given-names>M</given-names>
</name>
<name>
<surname>Nazarov</surname> <given-names>Z</given-names>
</name>
</person-group>. <article-title>Parent-reported height and weight as sources of bias in survey estimates of childhood obesity</article-title>. <source>Am J Epidemiol</source>. (<year>2013</year>) <volume>178</volume>:<page-range>461&#x2013;73</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/aje/kws477</pub-id>, PMID: <pub-id pub-id-type="pmid">23785115</pub-id></citation></ref>
<ref id="B55">
<label>55</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bosch</surname> <given-names>R</given-names>
</name>
<name>
<surname>Pagerols</surname> <given-names>M</given-names>
</name>
<name>
<surname>Rivas</surname> <given-names>C</given-names>
</name>
<name>
<surname>Sixto</surname> <given-names>L</given-names>
</name>
<name>
<surname>Bricoll&#xe9;</surname> <given-names>L</given-names>
</name>
<name>
<surname>Espa&#xf1;ol-Mart&#xed;n</surname> <given-names>G</given-names>
</name>
<etal/>
</person-group>. <article-title>Neurodevelopmental disorders among Spanish school-age children: prevalence and sociodemographic correlates</article-title>. <source>psychol Med</source>. (<year>2022</year>) <volume>52</volume>:<page-range>3062&#x2013;72</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1017/s0033291720005115</pub-id>, PMID: <pub-id pub-id-type="pmid">33436129</pub-id></citation></ref>
<ref id="B56">
<label>56</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Canals</surname> <given-names>J</given-names>
</name>
<name>
<surname>Morales-Hidalgo</surname> <given-names>P</given-names>
</name>
<name>
<surname>Jan&#xe9;</surname> <given-names>MC</given-names>
</name>
<name>
<surname>Dom&#xe8;nech</surname> <given-names>E</given-names>
</name>
</person-group>. <article-title>ADHD prevalence in Spanish preschoolers: comorbidity, socio-demographic factors, and functional consequences</article-title>. <source>J attention Disord</source>. (<year>2018</year>) <volume>22</volume>:<page-range>143&#x2013;53</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1177/1087054716638511</pub-id>, PMID: <pub-id pub-id-type="pmid">27009923</pub-id></citation></ref>
<ref id="B57">
<label>57</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peterson</surname> <given-names>BS</given-names>
</name>
<name>
<surname>Trampush</surname> <given-names>J</given-names>
</name>
<name>
<surname>Brown</surname> <given-names>M</given-names>
</name>
<name>
<surname>Maglione</surname> <given-names>M</given-names>
</name>
<name>
<surname>Bolshakova</surname> <given-names>M</given-names>
</name>
<name>
<surname>Rozelle</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Tools for the diagnosis of ADHD in children and adolescents: A systematic review</article-title>. <source>Pediatrics</source>. (<year>2024</year>) <volume>153</volume>:<elocation-id>e2024065854</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1542/peds.2024-065854</pub-id>, PMID: <pub-id pub-id-type="pmid">38523599</pub-id></citation></ref>
<ref id="B58">
<label>58</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Joly</surname> <given-names>O</given-names>
</name>
<name>
<surname>Frank&#xf3;</surname> <given-names>E</given-names>
</name>
</person-group>. <article-title>Neuroimaging of amblyopia and binocular vision: A review</article-title>. <source>Front Integr Neurosci</source>. (<year>2014</year>) <volume>8</volume>:<elocation-id>62</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fnint.2014.00062</pub-id>, PMID: <pub-id pub-id-type="pmid">25147511</pub-id></citation></ref>
</ref-list>
</back>
</article>